Changes in 7e1cf4f: fix links

				ABCA3.md
			
          @@ -14,7 +14,7 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_ABCA3.md]]

          +[[include:tables/DLBCL_ABCA3.md]]

           [[include:mermaid_ABCA3.md]]

				ABL2.md
			
          @@ -14,7 +14,7 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:FL_ABL2.md]]

          +[[include:tables/FL_ABL2.md]]

           ## Mutation pattern and selective pressure estimates

				ACAD9.md
			
          @@ -24,7 +24,7 @@ Due to [minimal support](ACAD9#representative-mutation) in the original primary 

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

           ### BL

          -[[include:BL_ACAD9]]

          +[[include:tables/BL_ACAD9]]

           ## Mutation pattern and selective pressure estimates

				ACE.md
			
          @@ -24,7 +24,7 @@ Due to [minimal support](ACE#representative-mutation) in the original primary da

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:BL_ACE]]

          +[[include:tables/BL_ACE]]

           ## Mutation pattern and selective pressure estimates

				ACSS2.md
			
          @@ -17,7 +17,7 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_ACSS2]]

          +[[include:tables/DLBCL_ACSS2]]

           [[include:mermaid_ACSS2.md]]

				ACSS3.md
			
          @@ -17,7 +17,7 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_ACSS3.md]]

          +[[include:tables/DLBCL_ACSS3.md]]

           [[include:mermaid_ACSS3.md]]

				ACTB.md
			
          @@ -21,12 +21,12 @@ ACTB is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm) 

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_ACTB.md]]

          -[[include:FL_ACTB.md]]

          +[[include:tables/DLBCL_ACTB.md]]

          +[[include:tables/FL_ACTB.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ACTB.md]]

          +[[include:tables/dnds_ACTB.md]]

           ## aSHM regions

				ACTG1.md
			
          @@ -23,12 +23,12 @@ The function of mutations in ACTB and ACTG1 have not yet been determined.[@witje

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_ACTG1.md]]

          -[[include:FL_ACTG1.md]]

          +[[include:tables/DLBCL_ACTG1.md]]

          +[[include:tables/FL_ACTG1.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ACTG1.md]]

          +[[include:tables/dnds_ACTG1.md]]

           ## aSHM regions

				ACTN1.md
			
          @@ -17,7 +17,7 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_ACTN1]]

          +[[include:tables/DLBCL_ACTN1]]

           [[include:mermaid_ACTN1.md]]

				ADAM2.md
			
          @@ -18,7 +18,7 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_ADAM2.md]]

          +[[include:tables/DLBCL_ADAM2.md]]

           [[include:mermaid_ADAM2.md]]

				ADAMTS1.md
			
          @@ -19,11 +19,11 @@ Mutations in this gene were first described in DLBCL in 2021 by Hübschmann et a

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_ADAMTS1]]

          +[[include:tables/DLBCL_ADAMTS1]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ADAMTS1.md]]

          +[[include:tables/dnds_ADAMTS1.md]]

				ADAMTS15.md
			
          @@ -17,7 +17,7 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_ADAMTS15.md]]

          +[[include:tables/DLBCL_ADAMTS15.md]]

           [[include:mermaid_ADAMTS15.md]]

				ADAMTS5.md
			
          @@ -16,11 +16,11 @@ nocite: |

           ### BL

          -[[include:BL_ADAMTS5.md]]

          +[[include:tables/BL_ADAMTS5.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ADAMTS5.md]]

          +[[include:tables/dnds_ADAMTS5.md]]

           [[include:browser_ADAMTS5.md]]

				ADAMTSL3.md
			
          @@ -17,7 +17,7 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_ADAMTSL3.md]]

          +[[include:tables/DLBCL_ADAMTSL3.md]]

           [[include:mermaid_ADAMTSL3.md]]

				ADH7.md
			
          @@ -17,7 +17,7 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_ADH7.md]]

          +[[include:tables/DLBCL_ADH7.md]]

           [[include:mermaid_ADH7.md]]

				ADNP.md
			
          @@ -14,11 +14,11 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:BL_ADNP.md]]

          +[[include:tables/BL_ADNP.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ADNP.md]]

          +[[include:tables/dnds_ADNP.md]]

				AFAP1L2.md
			
          @@ -18,11 +18,11 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_AFAP1L2.md]]

          +[[include:tables/DLBCL_AFAP1L2.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_AFAP1L2.md]]

          +[[include:tables/dnds_AFAP1L2.md]]

           [[include:mermaid_AFAP1L2.md]]

				AGO4.md
			
          @@ -14,11 +14,11 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:BL_AGO4]]

          +[[include:tables/BL_AGO4]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_AGO4.md]]

          +[[include:tables/dnds_AGO4.md]]

				AICDA.md
			
          @@ -14,11 +14,11 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_AICDA.md]]

          +[[include:tables/DLBCL_AICDA.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_AICDA.md]]

          +[[include:tables/dnds_AICDA.md]]

           ## aSHM regions

				ALAS1.md
			
          @@ -17,7 +17,7 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_ALAS1]]

          +[[include:tables/DLBCL_ALAS1]]

           [[include:mermaid_ALAS1.md]]

				ALPK2.md
			
          @@ -20,11 +20,11 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:BL_ALPK2.md]]

          +[[include:tables/BL_ALPK2.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ALPK2.md]]

          +[[include:tables/dnds_ALPK2.md]]

				ANK2.md
			
          @@ -20,7 +20,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ANK2.md]]

          +[[include:tables/dnds_ANK2.md]]

				ANKRD12.md
			
          @@ -27,7 +27,7 @@ Mutations in this gene were first described in DLBCL in 2021 by Hübschmann et a

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ANKRD12.md]]

          +[[include:tables/dnds_ANKRD12.md]]

           [[include:browser_ANKRD12.md]]

				ANKRD17.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ANKRD17.md]]

          +[[include:tables/dnds_ANKRD17.md]]

           [[include:browser_ANKRD17.md]]

				ARHGEF1.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ARHGEF1.md]]

          +[[include:tables/dnds_ARHGEF1.md]]

				ARID1A.md
			
          @@ -23,14 +23,14 @@ Driver mutations affecting this gene have been experimentally demonstrated to ca

           ## Mutation incidence in large cohorts

          -[[include:DLBCL_ARID1A.md]]

          -[[include:FL_ARID1A.md]]

          -[[include:BL_ARID1A.md]]

          +[[include:tables/DLBCL_ARID1A.md]]

          +[[include:tables/FL_ARID1A.md]]

          +[[include:tables/BL_ARID1A.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ARID1A.md]]

          +[[include:tables/dnds_ARID1A.md]]

           [[include:browser_ARID1A.md]]

				ARID1B.md
			
          @@ -30,7 +30,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ARID1B.md]]

          +[[include:tables/dnds_ARID1B.md]]

           [[include:browser_ARID1B.md]]

				ARID5B.md
			
          @@ -29,7 +29,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ARID5B.md]]

          +[[include:tables/dnds_ARID5B.md]]

           [[include:browser_ARID5B.md]]

				ATM.md
			
          @@ -23,11 +23,11 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_ATM.md]]

          +[[include:tables/DLBCL_ATM.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ATM.md]]

          +[[include:tables/dnds_ATM.md]]

           [[include:browser_ATM.md]]

				ATP2C2.md
			
          @@ -33,7 +33,7 @@ Due to [minimal support](ATP2C2#representative-mutation) in the original primary

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ATP2C2.md]]

          +[[include:tables/dnds_ATP2C2.md]]

				ATP6AP1.md
			
          @@ -14,11 +14,11 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:FL_ATP6AP1.md]]

          +[[include:tables/FL_ATP6AP1.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ATP6AP1.md]]

          +[[include:tables/dnds_ATP6AP1.md]]

           [[include:browser_ATP6AP1.md]]

				ATP6V1A.md
			
          @@ -24,7 +24,7 @@ Mutations in this gene were first described in DLBCL in 2021 by Hübschmann et a

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ATP6V1A.md]]

          +[[include:tables/dnds_ATP6V1A.md]]

           ## ATP6V1A Hotspots

				ATP6V1B2.md
			
          @@ -18,11 +18,11 @@ Driver mutations affecting this gene in FL have been experimentally demonstrated

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:FL_ATP6V1B2.md]]

          +[[include:tables/FL_ATP6V1B2.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ATP6V1B2.md]]

          +[[include:tables/dnds_ATP6V1B2.md]]

           ## ATP6V1B2 Hotspots

				ATR.md
			
          @@ -27,7 +27,7 @@ Mutations in this gene were first described in DLBCL in 2017 by Reddy et al.[@re

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ATR.md]]

          +[[include:tables/dnds_ATR.md]]

           [[include:browser_ATR.md]]

				B2M.md
			
          @@ -24,12 +24,12 @@ B2M mutations in B-cell lymphomas, particularly in DLBCL and PMBCL, lead to redu

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_B2M.md]]

          -[[include:FL_B2M.md]]

          +[[include:tables/DLBCL_B2M.md]]

          +[[include:tables/FL_B2M.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_B2M.md]]

          +[[include:tables/dnds_B2M.md]]

           ## B2M Hotspots

				BACH2.md
			
          @@ -22,11 +22,11 @@ Driver mutations affecting this gene in BL have been experimentally demonstrated

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:BL_BACH2.md]]

          +[[include:tables/BL_BACH2.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_BACH2.md]]

          +[[include:tables/dnds_BACH2.md]]

           ## aSHM regions

				BCL10.md
			
          @@ -26,13 +26,13 @@ BCL10 missense mutations in the CARD domain and truncating mutations have distin

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_BCL10.md]]

          -[[include:FL_BCL10.md]]

          +[[include:tables/DLBCL_BCL10.md]]

          +[[include:tables/FL_BCL10.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_BCL10.md]]

          +[[include:tables/dnds_BCL10.md]]

           ## BCL10 Hotspots

				BCL11A.md
			
          @@ -28,7 +28,7 @@ BCL11A (B-cell lymphoma/leukemia 11A) is a transcription factor involved in the 

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_BCL11A.md]]

          +[[include:tables/dnds_BCL11A.md]]

           ## aSHM regions

				BCL2.md
			
          @@ -22,17 +22,17 @@ Although missense mutations may not be under positive selective pressure in the 

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

           ### DLBCL

          -[[include:DLBCL_BCL2.md]]

          +[[include:tables/DLBCL_BCL2.md]]

           ### FL

          -[[include:FL_BCL2.md]]

          +[[include:tables/FL_BCL2.md]]

           ### BL

          -[[include:BL_BCL2.md]]

          +[[include:tables/BL_BCL2.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_BCL2.md]]

          +[[include:tables/dnds_BCL2.md]]

           ## aSHM regions

				BCL6.md
			
          @@ -25,17 +25,17 @@ Driver mutations affecting this gene in BL/FL/DLBCL have been experimentally dem

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

           ### DLBCL

          -[[include:DLBCL_BCL6.md]]

          +[[include:tables/DLBCL_BCL6.md]]

           ### FL

          -[[include:FL_BCL6.md]]

          +[[include:tables/FL_BCL6.md]]

           ### BL

          -[[include:BL_BCL6.md]]

          +[[include:tables/BL_BCL6.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_BCL6.md]]

          +[[include:tables/dnds_BCL6.md]]

           ## aSHM regions

				BCL7A.md
			
          @@ -27,17 +27,17 @@ Driver mutations affecting this gene in BL/DLBCL/FL have been experimentally dem

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

           ### DLBCL

          -[[include:DLBCL_BCL7A.md]]

          +[[include:tables/DLBCL_BCL7A.md]]

           ### FL

          -[[include:FL_BCL7A.md]]

          +[[include:tables/FL_BCL7A.md]]

           ### BL

          -[[include:BL_BCL7A.md]]

          +[[include:tables/BL_BCL7A.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_BCL7A.md]]

          +[[include:tables/dnds_BCL7A.md]]

           ## aSHM regions

				BCR.md
			
          @@ -28,7 +28,7 @@ BCR (Breakpoint Cluster Region Protein) is one of [a number of genes](https://gi

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_BCR.md]]

          +[[include:tables/dnds_BCR.md]]

           ## aSHM regions

				BIRC3.md
			
          @@ -24,7 +24,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_BIRC3.md]]

          +[[include:tables/dnds_BIRC3.md]]

           ## aSHM regions

				BIRC6.md
			
          @@ -19,12 +19,12 @@ BIRC6, as a negative regulator of non-canonical NF-κB signaling, is implicated 

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_BIRC6.md]]

          -[[include:FL_BIRC6.md]]

          +[[include:tables/DLBCL_BIRC6.md]]

          +[[include:tables/FL_BIRC6.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_BIRC6.md]]

          +[[include:tables/dnds_BIRC6.md]]

           ## BIRC6 Hotspots

				BLK.md
			
          @@ -10,7 +10,7 @@ nocite: |

           |Entity|Tier|Description                              |

           |:------:|:----:|-----------------------------------------|

          -|![DLBCL](images/icons/DLBCL_tier2.png) |2-a | aSHM target; Although recurrent, the relevance of mutations in DLBCL is tenuous |

          +|![DLBCL](images/icons/tables/DLBCL_tier2.png) |2-a | aSHM target; Although recurrent, the relevance of mutations in DLBCL is tenuous |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

				BMP7.md
			
          @@ -14,11 +14,11 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:BL_BMP7.md]]

          +[[include:tables/BL_BMP7.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_BMP7.md]]

          +[[include:tables/dnds_BMP7.md]]

           ## BMP7 Hotspots

				BRAF.md
			
          @@ -30,11 +30,11 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_BRAF.md]]

          +[[include:tables/DLBCL_BRAF.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_BRAF.md]]

          +[[include:tables/dnds_BRAF.md]]

           ## BRAF Hotspots

				BRD4.md
			
          @@ -31,7 +31,7 @@ Due to [minimal support](BRD4#representative-mutation) in the original primary d

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_BRD4.md]]

          +[[include:tables/dnds_BRD4.md]]

				BRINP3.md
			
          @@ -25,14 +25,14 @@ Details[@drevalRevisitingReddyDLBCL2023]

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

           ### DLBCL

          -[[include:DLBCL_BRINP3.md]]

          +[[include:tables/DLBCL_BRINP3.md]]

           ### BL

          -[[include:BL_BRINP3.md]]

          +[[include:tables/BL_BRINP3.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_BRINP3.md]]

          +[[include:tables/dnds_BRINP3.md]]

           [[include:browser_BRINP3.md]]

				BTBD3.md
			
          @@ -27,7 +27,7 @@ Mutations in this gene were first described in DLBCL in 2013[@zhangGeneticHetero

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_BTBD3.md]]

          +[[include:tables/dnds_BTBD3.md]]

           [[include:browser_BTBD3.md]]

				BTG1.md
			
          @@ -26,17 +26,17 @@ Another study demonstrated that specific BTG1 mutations afford germinal center (

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

           ### DLBCL

          -[[include:DLBCL_BTG1.md]]

          +[[include:tables/DLBCL_BTG1.md]]

           ### FL

          -[[include:FL_BTG1.md]]

          +[[include:tables/FL_BTG1.md]]

           ### BL

          -[[include:BL_BTG1.md]]

          +[[include:tables/BL_BTG1.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_BTG1.md]]

          +[[include:tables/dnds_BTG1.md]]

           ## aSHM regions

				BTG2.md
			
          @@ -25,12 +25,12 @@ BTG2 is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm) 

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_BTG2.md]]

          -[[include:FL_BTG2.md]]

          +[[include:tables/DLBCL_BTG2.md]]

          +[[include:tables/FL_BTG2.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_BTG2.md]]

          +[[include:tables/dnds_BTG2.md]]

           ## aSHM regions

				BTK.md
			
          @@ -19,12 +19,12 @@ Driver mutations affecting this gene in FL/DLBCL have been experimentally demons

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_BTK.md]]

          -[[include:FL_BTK.md]]

          +[[include:tables/DLBCL_BTK.md]]

          +[[include:tables/FL_BTK.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_BTK.md]]

          +[[include:tables/dnds_BTK.md]]

           [[include:browser_BTK.md]]

				CAD.md
			
          @@ -31,7 +31,7 @@ Due to [minimal support](CAD#representative-mutation) in the original primary da

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CAD.md]]

          +[[include:tables/dnds_CAD.md]]

				CADPS2.md
			
          @@ -27,7 +27,7 @@ Mutations in this gene were first described in DLBCL in 2021 by Hübschmann et a

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CADPS2.md]]

          +[[include:tables/dnds_CADPS2.md]]

           [[include:browser_CADPS2.md]]

				CARD11.md
			
          @@ -25,14 +25,14 @@ The functional effect of CARD11 mutations in DLBCL was explored in the original 

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

           ### DLBCL

          -[[include:DLBCL_CARD11.md]]

          +[[include:tables/DLBCL_CARD11.md]]

           ### FL

          -[[include:FL_CARD11.md]]

          +[[include:tables/FL_CARD11.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CARD11.md]]

          +[[include:tables/dnds_CARD11.md]]

           ## CARD11 Hotspots

				CASP8.md
			
          @@ -28,7 +28,7 @@ Mutations in this gene were first described in DLBCL in 2017 by Reddy et al.[@re

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CASP8.md]]

          +[[include:tables/dnds_CASP8.md]]

				CBLB.md
			
          @@ -31,7 +31,7 @@ Mutations in this gene were first described in DLBCL in 2017 by Reddy et al.[@re

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CBLB.md]]

          +[[include:tables/dnds_CBLB.md]]

           [[include:browser_CBLB.md]]

				CCL4.md
			
          @@ -24,7 +24,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CCL4.md]]

          +[[include:tables/dnds_CCL4.md]]

				CCND3.md
			
          @@ -21,13 +21,13 @@ Somatic mutations in CCND3 often stabilize the Cyclin D3 protein by altering the

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_CCND3.md]]

          -[[include:FL_CCND3.md]]

          -[[include:BL_CCND3.md]]

          +[[include:tables/DLBCL_CCND3.md]]

          +[[include:tables/FL_CCND3.md]]

          +[[include:tables/BL_CCND3.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CCND3.md]]

          +[[include:tables/dnds_CCND3.md]]

           ## CCND3 Hotspots

				CCNF.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CCNF.md]]

          +[[include:tables/dnds_CCNF.md]]

           [[include:browser_CCNF.md]]

				CCT6B.md
			
          @@ -32,7 +32,7 @@ Due to [minimal support](CCT6B#representative-mutations) in the original primary

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CCT6B.md]]

          +[[include:tables/dnds_CCT6B.md]]

				CD22.md
			
          @@ -27,7 +27,7 @@ Mutations in this gene were first described in DLBCL in 2017 by Reddy et al.[@re

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CD22.md]]

          +[[include:tables/dnds_CD22.md]]

           [[include:browser_CD22.md]]

				CD274.md
			
          @@ -27,7 +27,7 @@ Although rare, mutations have the potential to impact PD-L1 expression and could

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CD274.md]]

          +[[include:tables/dnds_CD274.md]]

				CD36.md
			
          @@ -27,7 +27,7 @@ CD36 is a transmembrane glycoprotein involved in fatty acid metabolism, glucose 

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CD36.md]]

          +[[include:tables/dnds_CD36.md]]

           ## Expression

				CD44.md
			
          @@ -24,7 +24,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CD44.md]]

          +[[include:tables/dnds_CD44.md]]

           ## aSHM regions

				CD58.md
			
          @@ -23,11 +23,11 @@ This is often accompanied by mutations in the β2-Microglobulin gene, which furt

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_CD58.md]]

          +[[include:tables/DLBCL_CD58.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CD58.md]]

          +[[include:tables/dnds_CD58.md]]

           [[include:browser_CD58.md]]

				CD70.md
			
          @@ -26,12 +26,12 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_CD70.md]]

          -[[include:FL_CD70.md]]

          +[[include:tables/DLBCL_CD70.md]]

          +[[include:tables/FL_CD70.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CD70.md]]

          +[[include:tables/dnds_CD70.md]]

           ## CD70 Hotspots

				CD74.md
			
          @@ -14,11 +14,11 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_CD74.md]]

          +[[include:tables/DLBCL_CD74.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CD74.md]]

          +[[include:tables/dnds_CD74.md]]

           ## aSHM regions

				CD79A.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CD79A.md]]

          +[[include:tables/dnds_CD79A.md]]

				CD79B.md
			
          @@ -29,14 +29,14 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

           ### DLBCL

          -[[include:DLBCL_CD79B.md]]

          +[[include:tables/DLBCL_CD79B.md]]

           ### FL

          -[[include:FL_CD79B.md]]

          +[[include:tables/FL_CD79B.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CD79B.md]]

          +[[include:tables/dnds_CD79B.md]]

           ## CD79B Hotspots

				CD83.md
			
          @@ -23,12 +23,12 @@ Mutations in this gene were first described in DLBCL in 2013 by Morin et al[@mor

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_CD83.md]]

          -[[include:FL_CD83.md]]

          +[[include:tables/DLBCL_CD83.md]]

          +[[include:tables/FL_CD83.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CD83.md]]

          +[[include:tables/dnds_CD83.md]]

           ## aSHM regions

				CDC73.md
			
          @@ -34,7 +34,7 @@ Mutations in this gene were first described in BL in 2012 by Love et al[@loveGen

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CDC73.md]]

          +[[include:tables/dnds_CDC73.md]]

           [[include:browser_CDC73.md]]

				CDH17.md
			
          @@ -31,7 +31,7 @@ Due to [minimal support](CDH17#representative-mutations) in the original primary

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CDH17.md]]

          +[[include:tables/dnds_CDH17.md]]

				CDH8.md
			
          @@ -21,7 +21,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CDH8.md]]

          +[[include:tables/dnds_CDH8.md]]

				CDH9.md
			
          @@ -24,7 +24,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CDH9.md]]

          +[[include:tables/dnds_CDH9.md]]

				CDKN2A.md
			
          @@ -21,7 +21,7 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_CDKN2A.md]]

          +[[include:tables/DLBCL_CDKN2A.md]]

           ## Mutation pattern and selective pressure estimates

				CDKN2C.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CDKN2C.md]]

          +[[include:tables/dnds_CDKN2C.md]]

				CHD1.md
			
          @@ -31,7 +31,7 @@ Mutations in this gene were first described in DLBCL in 2017 by Reddy et al.[@re

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CHD1.md]]

          +[[include:tables/dnds_CHD1.md]]

           [[include:browser_CHD1.md]]

				CHD4.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CHD4.md]]

          +[[include:tables/dnds_CHD4.md]]

				CHD8.md
			
          @@ -18,12 +18,12 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_CHD8.md]]

          -[[include:BL_CHD8.md]]

          +[[include:tables/DLBCL_CHD8.md]]

          +[[include:tables/BL_CHD8.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CHD8.md]]

          +[[include:tables/dnds_CHD8.md]]

           [[include:browser_CHD8.md]]

				CHST2.md
			
          @@ -31,7 +31,7 @@ Mutations in this gene were first described in DLBCL in 2017 by Reddy et al.[@re

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CHST2.md]]

          +[[include:tables/dnds_CHST2.md]]

           [[include:browser_CHST2.md]]

				CIITA.md
			
          @@ -21,12 +21,12 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_CIITA.md]]

          -[[include:FL_CIITA.md]]

          +[[include:tables/DLBCL_CIITA.md]]

          +[[include:tables/FL_CIITA.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CIITA.md]]

          +[[include:tables/dnds_CIITA.md]]

           ## aSHM regions

				CILP.md
			
          @@ -21,7 +21,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CILP.md]]

          +[[include:tables/dnds_CILP.md]]

				CNOT2.md
			
          @@ -27,7 +27,7 @@ Mutations in this gene were first described in DLBCL in 2021 by Hübschmann et a

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CNOT2.md]]

          +[[include:tables/dnds_CNOT2.md]]

           [[include:browser_CNOT2.md]]

				CNTNAP5.md
			
          @@ -27,7 +27,7 @@ Mutations in this gene were first described in DLBCL in 2013 by Morin et al.[@mo

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CNTNAP5.md]]

          +[[include:tables/dnds_CNTNAP5.md]]

           [[include:browser_CNTNAP5.md]]

				COL4A2.md
			
          @@ -33,7 +33,7 @@ Due to [minimal support](COL4A2#representative-mutations) in the original primar

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_COL4A2.md]]

          +[[include:tables/dnds_COL4A2.md]]

				COQ7.md
			
          @@ -24,7 +24,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_COQ7.md]]

          +[[include:tables/dnds_COQ7.md]]

				CPNE8.md
			
          @@ -24,7 +24,7 @@ Mutations in this gene were first described in FL in 2021 by Hübschmann et al.[

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CPNE8.md]]

          +[[include:tables/dnds_CPNE8.md]]

				CPXM2.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CPXM2.md]]

          +[[include:tables/dnds_CPXM2.md]]

				CREBBP.md
			
          @@ -25,13 +25,13 @@ Mutations in CREBBP and EP300 affect a common pathway and have been described as

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_CREBBP.md]]

          -[[include:FL_CREBBP.md]]

          -[[include:BL_CREBBP.md]]

          +[[include:tables/DLBCL_CREBBP.md]]

          +[[include:tables/FL_CREBBP.md]]

          +[[include:tables/BL_CREBBP.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CREBBP.md]]

          +[[include:tables/dnds_CREBBP.md]]

           ## CREBBP Hotspots

				CRIP1.md
			
          @@ -24,7 +24,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CRIP1.md]]

          +[[include:tables/dnds_CRIP1.md]]

				CTCF.md
			
          @@ -27,7 +27,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CTCF.md]]

          +[[include:tables/dnds_CTCF.md]]

				CTSS.md
			
          @@ -19,12 +19,12 @@ Driver mutations affecting this gene in FL have been experimentally demonstrated

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_CTSS.md]]

          -[[include:FL_CTSS.md]]

          +[[include:tables/DLBCL_CTSS.md]]

          +[[include:tables/FL_CTSS.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CTSS.md]]

          +[[include:tables/dnds_CTSS.md]]

           ## CTSS Hotspots

				CXCR4.md
			
          @@ -25,12 +25,12 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_CXCR4.md]]

          -[[include:FL_CXCR4.md]]

          +[[include:tables/DLBCL_CXCR4.md]]

          +[[include:tables/FL_CXCR4.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CXCR4.md]]

          +[[include:tables/dnds_CXCR4.md]]

           ## aSHM regions

				CXCR5.md
			
          @@ -27,7 +27,7 @@ CXCR5 is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm)

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CXCR5.md]]

          +[[include:tables/dnds_CXCR5.md]]

           ## aSHM regions

				CYB5D1.md
			
          @@ -29,7 +29,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CYB5D1.md]]

          +[[include:tables/dnds_CYB5D1.md]]

				CYP2A6.md
			
          @@ -21,7 +21,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CYP2A6.md]]

          +[[include:tables/dnds_CYP2A6.md]]

				CYP4F22.md
			
          @@ -31,7 +31,7 @@ Due to [minimal support](CYP4F22#representative-mutation) in the original primar

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_CYP4F22.md]]

          +[[include:tables/dnds_CYP4F22.md]]

           [[include:browser_CYP4F22.md]]

				DAZAP1.md
			
          @@ -27,7 +27,7 @@ This gene has some recurrent sites of mutations (hot spots). The mutation patter

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_DAZAP1.md]]

          +[[include:tables/dnds_DAZAP1.md]]

           ## DAZAP1 Hotspots

				DCAF6.md
			
          @@ -31,7 +31,7 @@ Mutations in this gene were first described in DLBCL in 2017 by Reddy et al.[@re

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_DCAF6.md]]

          +[[include:tables/dnds_DCAF6.md]]

				DDX10.md
			
          @@ -24,7 +24,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_DDX10.md]]

          +[[include:tables/dnds_DDX10.md]]

				DDX3X.md
			
          @@ -22,13 +22,13 @@ Driver mutations affecting this gene in DLBCL/BL have been experimentally demons

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_DDX3X.md]]

          -[[include:FL_DDX3X.md]]

          -[[include:BL_DDX3X.md]]

          +[[include:tables/DLBCL_DDX3X.md]]

          +[[include:tables/FL_DDX3X.md]]

          +[[include:tables/BL_DDX3X.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_DDX3X.md]]

          +[[include:tables/dnds_DDX3X.md]]

           ## aSHM regions

				DHX15.md
			
          @@ -24,7 +24,7 @@ Mutations in this gene were first described in FL in 2021 by Hübschmann et al.[

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_DHX15.md]]

          +[[include:tables/dnds_DHX15.md]]

				DHX16.md
			
          @@ -27,7 +27,7 @@ Mutations in this gene were first described in DLBCL in 2021 by Hübschmann et a

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_DHX16.md]]

          +[[include:tables/dnds_DHX16.md]]

				DICER1.md
			
          @@ -30,7 +30,7 @@ Mutations in this gene were reported to be inflated in the original results acco

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_DICER1.md]]

          +[[include:tables/dnds_DICER1.md]]

				DLBCL.md
			
          @@ -1,2 +1,2 @@

           [EZH2](EZH2)## DLBCL Expression

          -![image](images/gene_expression/DLBCL_by_pathology.svg)

          +![image](images/gene_expression/tables/DLBCL_by_pathology.svg)

				DLGAP1.md
			
          @@ -30,7 +30,7 @@ Due to [minimal support](DLGAP1#representative-mutation) in the original primary

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_DLGAP1.md]]

          +[[include:tables/dnds_DLGAP1.md]]

				DNAH5.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_DNAH5.md]]

          +[[include:tables/dnds_DNAH5.md]]

				DNM2.md
			
          @@ -27,7 +27,7 @@ Mutations in this gene were first described in DLBCL and FL in 2021 by Hübschma

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_DNM2.md]]

          +[[include:tables/dnds_DNM2.md]]

           ## DNM2 Hotspots

				DNMT1.md
			
          @@ -26,7 +26,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_DNMT1.md]]

          +[[include:tables/dnds_DNMT1.md]]

				DNMT3A.md
			
          @@ -30,7 +30,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_DNMT3A.md]]

          +[[include:tables/dnds_DNMT3A.md]]

				DOCK1.md
			
          @@ -24,7 +24,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_DOCK1.md]]

          +[[include:tables/dnds_DOCK1.md]]

				DSG4.md
			
          @@ -24,7 +24,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_DSG4.md]]

          +[[include:tables/dnds_DSG4.md]]

				DTX1.md
			
          @@ -18,12 +18,12 @@ Mutations in the DTX1 gene, which encodes the E3 ubiquitin ligase Deltex 1, have

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_DTX1.md]]

          -[[include:FL_DTX1.md]]

          +[[include:tables/DLBCL_DTX1.md]]

          +[[include:tables/FL_DTX1.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_DTX1.md]]

          +[[include:tables/dnds_DTX1.md]]

           ## aSHM regions

				DUSP2.md
			
          @@ -23,12 +23,12 @@ The mutation pattern in DLBCL implies the preferential accumulation of *inactiva

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_DUSP2.md]]

          -[[include:FL_DUSP2.md]]

          +[[include:tables/DLBCL_DUSP2.md]]

          +[[include:tables/FL_DUSP2.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_DUSP2.md]]

          +[[include:tables/dnds_DUSP2.md]]

           ## aSHM regions

				E2F2.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_E2F2.md]]

          +[[include:tables/dnds_E2F2.md]]

				EBF1.md
			
          @@ -23,12 +23,12 @@ Driver mutations affecting this gene in DLBCL/FL have been experimentally demons

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_EBF1.md]]

          -[[include:FL_EBF1.md]]

          +[[include:tables/DLBCL_EBF1.md]]

          +[[include:tables/FL_EBF1.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_EBF1.md]]

          +[[include:tables/dnds_EBF1.md]]

           ## aSHM regions

				EDNRB.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_EDNRB.md]]

          +[[include:tables/dnds_EDNRB.md]]

				EEF1A1.md
			
          @@ -18,12 +18,12 @@ This gene has some recurrent sites of mutations (hot spots). The mutation patter

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_EEF1A1.md]]

          -[[include:FL_EEF1A1.md]]

          +[[include:tables/DLBCL_EEF1A1.md]]

          +[[include:tables/FL_EEF1A1.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_EEF1A1.md]]

          +[[include:tables/dnds_EEF1A1.md]]

           ## EEF1A1 Hotspots

				EHD1.md
			
          @@ -21,7 +21,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_EHD1.md]]

          +[[include:tables/dnds_EHD1.md]]

				EIF2AK3.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_EIF2AK3.md]]

          +[[include:tables/dnds_EIF2AK3.md]]

				EIF4A1.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_EIF4A1.md]]

          +[[include:tables/dnds_EIF4A1.md]]

           [[include:browser_EIF4A1.md]]

				EML2.md
			
          @@ -33,7 +33,7 @@ Due to [minimal support](EML2#representative-mutation) in the original primary d

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_EML2.md]]

          +[[include:tables/dnds_EML2.md]]

           [[include:browser_EML2.md]]

				ENTPD3.md
			
          @@ -29,7 +29,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ENTPD3.md]]

          +[[include:tables/dnds_ENTPD3.md]]

				EP300.md
			
          @@ -22,12 +22,12 @@ Studies using genome-wide CRISPR-Cas9 screens have identified synthetic lethal i

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_EP300.md]]

          -[[include:FL_EP300.md]]

          +[[include:tables/DLBCL_EP300.md]]

          +[[include:tables/FL_EP300.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_EP300.md]]

          +[[include:tables/dnds_EP300.md]]

           ## EP300 Hotspots

				EPHB2.md
			
          @@ -23,11 +23,11 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:BL_EPHB2.md]]

          +[[include:tables/BL_EPHB2.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_EPHB2.md]]

          +[[include:tables/dnds_EPHB2.md]]

				EPPK1.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_EPPK1.md]]

          +[[include:tables/dnds_EPPK1.md]]

           ## EPPK1 Hotspots

				ERAP1.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ERAP1.md]]

          +[[include:tables/dnds_ERAP1.md]]

				ETS1.md
			
          @@ -26,12 +26,12 @@ The mutation pattern in DLBCL implies the preferential accumulation of *inactiva

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_ETS1.md]]

          -[[include:FL_ETS1.md]]

          +[[include:tables/DLBCL_ETS1.md]]

          +[[include:tables/FL_ETS1.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ETS1.md]]

          +[[include:tables/dnds_ETS1.md]]

           ## aSHM regions

				ETV6.md
			
          @@ -26,11 +26,11 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_ETV6.md]]

          +[[include:tables/DLBCL_ETV6.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ETV6.md]]

          +[[include:tables/dnds_ETV6.md]]

           ## aSHM regions

				EXOSC6.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_EXOSC6.md]]

          +[[include:tables/dnds_EXOSC6.md]]

				EZH2.md
			
          @@ -28,12 +28,12 @@ Combination therapies including EZH2 inhibitors are also under exploration for D

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_EZH2.md]]

          -[[include:FL_EZH2.md]]

          +[[include:tables/DLBCL_EZH2.md]]

          +[[include:tables/FL_EZH2.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_EZH2.md]]

          +[[include:tables/dnds_EZH2.md]]

           ## EZH2 Hotspots

				FAM102A.md
			
          @@ -11,7 +11,7 @@ nocite: |

           |Entity|Tier|Description                              |

           |:------:|:----:|-----------------------------------------|

          -|![DLBCL](images/icons/DLBCL_tier2.png) |2-a | aSHM target; Although recurrent, the relevance of mutations in DLBCL is tenuous |

          +|![DLBCL](images/icons/tables/DLBCL_tier2.png) |2-a | aSHM target; Although recurrent, the relevance of mutations in DLBCL is tenuous |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

				FANK1.md
			
          @@ -11,7 +11,7 @@ nocite: |

           |Entity|Tier|Description                              |

           |:------:|:----:|-----------------------------------------|

          -|![DLBCL](images/icons/DLBCL_tier2.png) |2-a | aSHM target; Although recurrent, the relevance of mutations in DLBCL is tenuous |

          +|![DLBCL](images/icons/tables/DLBCL_tier2.png) |2-a | aSHM target; Although recurrent, the relevance of mutations in DLBCL is tenuous |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

				FAS.md
			
          @@ -25,12 +25,12 @@ Driver mutations affecting this gene in FL/DLBCL have been experimentally demons

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_FAS.md]]

          -[[include:FL_FAS.md]]

          +[[include:tables/DLBCL_FAS.md]]

          +[[include:tables/FL_FAS.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_FAS.md]]

          +[[include:tables/dnds_FAS.md]]

           [[include:browser_FAS.md]]

				FAT4.md
			
          @@ -24,7 +24,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_FAT4.md]]

          +[[include:tables/dnds_FAT4.md]]

				FBXO11.md
			
          @@ -23,12 +23,12 @@ Driver mutations affecting this gene in DLBCL/BL have been experimentally demons

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_FBXO11.md]]

          -[[include:BL_FBXO11.md]]

          +[[include:tables/DLBCL_FBXO11.md]]

          +[[include:tables/BL_FBXO11.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_FBXO11.md]]

          +[[include:tables/dnds_FBXO11.md]]

           ## FBXO11 hot spots

           |Chromosome|Coordinate|Mutation|HGVSp|

				FBXW7.md
			
          @@ -24,11 +24,11 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_FBXW7.md]]

          +[[include:tables/DLBCL_FBXW7.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_FBXW7.md]]

          +[[include:tables/dnds_FBXW7.md]]

				FCRL3.md
			
          @@ -11,7 +11,7 @@ nocite: |

           |Entity|Tier|Description                              |

           |:------:|:----:|-----------------------------------------|

          -|![DLBCL](images/icons/DLBCL_tier2.png) |2 | aSHM target; Although recurrent, the relevance of mutations in DLBCL is tenuous |

          +|![DLBCL](images/icons/tables/DLBCL_tier2.png) |2 | aSHM target; Although recurrent, the relevance of mutations in DLBCL is tenuous |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

				FGFR3.md
			
          @@ -32,7 +32,7 @@ Due to [minimal support](FGFR3#representative-mutation) in the original primary 

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_FGFR3.md]]

          +[[include:tables/dnds_FGFR3.md]]

				FLYWCH1.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_FLYWCH1.md]]

          +[[include:tables/dnds_FLYWCH1.md]]

				FNBP1.md
			
          @@ -11,7 +11,7 @@ nocite: |

           |Entity|Tier|Description                              |

           |:------:|:----:|-----------------------------------------|

          -|![DLBCL](images/icons/DLBCL_tier2.png) |2-a | aSHM target; Although recurrent, the relevance of mutations in DLBCL is tenuous |

          +|![DLBCL](images/icons/tables/DLBCL_tier2.png) |2-a | aSHM target; Although recurrent, the relevance of mutations in DLBCL is tenuous |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

				FNDC1.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_FNDC1.md]]

          +[[include:tables/dnds_FNDC1.md]]

				FOXC1.md
			
          @@ -25,7 +25,7 @@ FOXC1 is a transcription factor that regulates genes involved in cell growth, di

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_FOXC1.md]]

          +[[include:tables/dnds_FOXC1.md]]

				FOXO1.md
			
          @@ -21,13 +21,13 @@ Driver mutations affecting this gene in FL/DLBCL/BL have been experimentally dem

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_FOXO1.md]]

          -[[include:FL_FOXO1.md]]

          -[[include:BL_FOXO1.md]]

          +[[include:tables/DLBCL_FOXO1.md]]

          +[[include:tables/FL_FOXO1.md]]

          +[[include:tables/BL_FOXO1.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_FOXO1.md]]

          +[[include:tables/dnds_FOXO1.md]]

           ## FOXO1 Hotspots

				FOXP1.md
			
          @@ -24,7 +24,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_FOXP1.md]]

          +[[include:tables/dnds_FOXP1.md]]

           ## aSHM regions

				FTCD.md
			
          @@ -35,7 +35,7 @@ Due to [minimal support](FTCD#representative-mutation) in the original primary d

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_FTCD.md]]

          +[[include:tables/dnds_FTCD.md]]

				FUBP1.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_FUBP1.md]]

          +[[include:tables/dnds_FUBP1.md]]

				FUT5.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_FUT5.md]]

          +[[include:tables/dnds_FUT5.md]]

				FZD3.md
			
          @@ -29,7 +29,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_FZD3.md]]

          +[[include:tables/dnds_FZD3.md]]

				FZR1.md
			
          @@ -24,7 +24,7 @@ Mutations in this gene were first described in DLBCL and FL in 2021 by Hübschma

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_FZR1.md]]

          +[[include:tables/dnds_FZR1.md]]

           [[include:browser_FZR1.md]]

				GABRA2.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_GABRA2.md]]

          +[[include:tables/dnds_GABRA2.md]]

				GAK.md
			
          @@ -27,7 +27,7 @@ Mutations in this gene were first described in DLBCL in 2021 by Hübschmann et a

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_GAK.md]]

          +[[include:tables/dnds_GAK.md]]

           [[include:browser_GAK.md]]

				GBP7.md
			
          @@ -20,7 +20,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_GBP7.md]]

          +[[include:tables/dnds_GBP7.md]]

				GNA13.md
			
          @@ -22,13 +22,13 @@ Driver mutations affecting this gene in BL/FL/DLBCL have been experimentally dem

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_GNA13.md]]

          -[[include:FL_GNA13.md]]

          -[[include:BL_GNA13.md]]

          +[[include:tables/DLBCL_GNA13.md]]

          +[[include:tables/FL_GNA13.md]]

          +[[include:tables/BL_GNA13.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_GNA13.md]]

          +[[include:tables/dnds_GNA13.md]]

           ## GNA13 Hotspots

				GNAI2.md
			
          @@ -23,13 +23,13 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_GNAI2.md]]

          -[[include:FL_GNAI2.md]]

          -[[include:BL_GNAI2.md]]

          +[[include:tables/DLBCL_GNAI2.md]]

          +[[include:tables/FL_GNAI2.md]]

          +[[include:tables/BL_GNAI2.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_GNAI2.md]]

          +[[include:tables/dnds_GNAI2.md]]

           ## GNAI2 Hotspots

				GNAS.md
			
          @@ -28,7 +28,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_GNAS.md]]

          +[[include:tables/dnds_GNAS.md]]

				GOLGA5.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_GOLGA5.md]]

          +[[include:tables/dnds_GOLGA5.md]]

				GPC5.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_GPC5.md]]

          +[[include:tables/dnds_GPC5.md]]

				GRB2.md
			
          @@ -20,11 +20,11 @@ Further research is needed to elucidate its specific role in DLBCL.

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_GRB2.md]]

          +[[include:tables/DLBCL_GRB2.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_GRB2.md]]

          +[[include:tables/dnds_GRB2.md]]

           [[include:browser_GRB2.md]]

				GRHPR.md
			
          @@ -17,11 +17,11 @@ GRHPR is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm)

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_GRHPR.md]]

          +[[include:tables/DLBCL_GRHPR.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_GRHPR.md]]

          +[[include:tables/dnds_GRHPR.md]]

           ## aSHM regions

				GRIK5.md
			
          @@ -27,7 +27,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_GRIK5.md]]

          +[[include:tables/dnds_GRIK5.md]]

				GRM6.md
			
          @@ -20,7 +20,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_GRM6.md]]

          +[[include:tables/dnds_GRM6.md]]

				GTSE1.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_GTSE1.md]]

          +[[include:tables/dnds_GTSE1.md]]

				HDAC7.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_HDAC7.md]]

          +[[include:tables/dnds_HDAC7.md]]

				HEPH.md
			
          @@ -20,7 +20,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_HEPH.md]]

          +[[include:tables/dnds_HEPH.md]]

				HIST1H1B.md
			
          @@ -18,17 +18,17 @@ This is one of several genes that encode linker histone proteins that are recurr

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

           ### DLBCL

          -[[include:DLBCL_HIST1H1B.md]]

          +[[include:tables/DLBCL_HIST1H1B.md]]

           ### FL

          -[[include:FL_HIST1H1B.md]]

          +[[include:tables/FL_HIST1H1B.md]]

           ### BL

          -[[include:BL_HIST1H1B.md]]

          +[[include:tables/BL_HIST1H1B.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_HIST1H1B.md]]

          +[[include:tables/dnds_HIST1H1B.md]]

           [[include:browser_HIST1H1B.md]]

				HIST1H1C.md
			
          @@ -27,19 +27,19 @@ Mutations are often found in the globular domain of the protein, which is critic

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

           ### DLBCL

          -[[include:DLBCL_HIST1H1C.md]]

          +[[include:tables/DLBCL_HIST1H1C.md]]

           ### BL

          -[[include:BL_HIST1H1C.md]]

          +[[include:tables/BL_HIST1H1C.md]]

           ### FL

          -[[include:FL_HIST1H1C.md]]

          +[[include:tables/FL_HIST1H1C.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_HIST1H1C.md]]

          +[[include:tables/dnds_HIST1H1C.md]]

           [[include:browser_HIST1H1C.md]]

				HIST1H1D.md
			
          @@ -19,17 +19,17 @@ Mutations are often found in the globular domain of the protein, which is critic

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

           ### DLBCL

          -[[include:DLBCL_HIST1H1D.md]]

          +[[include:tables/DLBCL_HIST1H1D.md]]

           ### BL

          -[[include:BL_HIST1H1D.md]]

          +[[include:tables/BL_HIST1H1D.md]]

           ### FL

          -[[include:FL_HIST1H1D.md]]

          +[[include:tables/FL_HIST1H1D.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_HIST1H1D.md]]

          +[[include:tables/dnds_HIST1H1D.md]]

				HIST1H1E.md
			
          @@ -21,13 +21,13 @@ Mutations in this gene were first described in DLBCL in 2013 by Morin et al.[@mo

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_HIST1H1E.md]]

          -[[include:FL_HIST1H1E.md]]

          -[[include:BL_HIST1H1E.md]]

          +[[include:tables/DLBCL_HIST1H1E.md]]

          +[[include:tables/FL_HIST1H1E.md]]

          +[[include:tables/BL_HIST1H1E.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_HIST1H1E.md]]

          +[[include:tables/dnds_HIST1H1E.md]]

           ## HIST1H1E Hotspots

				HIST1H2AC.md
			
          @@ -19,17 +19,17 @@ This gene encodes the H2A protein, one of the core proteins comprising nucleosom

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

           ### DLBCL

          -[[include:DLBCL_HIST1H2AC.md]]

          +[[include:tables/DLBCL_HIST1H2AC.md]]

           ### BL

          -[[include:BL_HIST1H2AC.md]]

          +[[include:tables/BL_HIST1H2AC.md]]

           ### FL

          -[[include:FL_HIST1H2AC.md]]

          +[[include:tables/FL_HIST1H2AC.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_HIST1H2AC.md]]

          +[[include:tables/dnds_HIST1H2AC.md]]

           ## HIST1H2AC Hotspots

				HIST1H2AM.md
			
          @@ -27,17 +27,17 @@ This gene encodes the H2A protein, one of the core proteins comprising nucleosom

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

           ### DLBCL

          -[[include:DLBCL_HIST1H2AM.md]]

          +[[include:tables/DLBCL_HIST1H2AM.md]]

           ### BL

          -[[include:BL_HIST1H2AM.md]]

          +[[include:tables/BL_HIST1H2AM.md]]

           ### FL

          -[[include:FL_HIST1H2AM.md]]

          +[[include:tables/FL_HIST1H2AM.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_HIST1H2AM.md]]

          +[[include:tables/dnds_HIST1H2AM.md]]

           ## HIST1H2AM Hotspots

				HIST1H2BC.md
			
          @@ -18,17 +18,17 @@ This gene encodes the H2A protein, one of the core proteins comprising nucleosom

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

           ### DLBCL

          -[[include:DLBCL_HIST1H2BC.md]]

          +[[include:tables/DLBCL_HIST1H2BC.md]]

           ### BL

          -[[include:BL_HIST1H2BC.md]]

          +[[include:tables/BL_HIST1H2BC.md]]

           ### FL

          -[[include:FL_HIST1H2BC.md]]

          +[[include:tables/FL_HIST1H2BC.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_HIST1H2BC.md]]

          +[[include:tables/dnds_HIST1H2BC.md]]

				HIST1H2BK.md
			
          @@ -25,16 +25,16 @@ This gene encodes the H2A protein, one of the core proteins comprising nucleosom

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

           ### DLBCL

          -[[include:DLBCL_HIST1H2BK.md]]

          +[[include:tables/DLBCL_HIST1H2BK.md]]

           ### BL

          -[[include:BL_HIST1H2BK.md]]

          +[[include:tables/BL_HIST1H2BK.md]]

           ### FL

          -[[include:FL_HIST1H2BK.md]]

          +[[include:tables/FL_HIST1H2BK.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_HIST1H2BK.md]]

          +[[include:tables/dnds_HIST1H2BK.md]]

				HIST1H3B.md
			
          @@ -15,17 +15,17 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

           ### DLBCL

          -[[include:DLBCL_HIST1H3B.md]]

          +[[include:tables/DLBCL_HIST1H3B.md]]

           ### BL

          -[[include:BL_HIST1H3B.md]]

          +[[include:tables/BL_HIST1H3B.md]]

           ### FL

          -[[include:FL_HIST1H3B.md]]

          +[[include:tables/FL_HIST1H3B.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_HIST1H3B.md]]

          +[[include:tables/dnds_HIST1H3B.md]]

				HIST2H2BE.md
			
          @@ -18,13 +18,13 @@ This gene encodes the H2A protein, one of the core proteins comprising nucleosom

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

           ### DLBCL

          -[[include:DLBCL_HIST2H2BE.md]]

          +[[include:tables/DLBCL_HIST2H2BE.md]]

           ### BL

          -[[include:BL_HIST2H2BE.md]]

          +[[include:tables/BL_HIST2H2BE.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_HIST2H2BE.md]]

          +[[include:tables/dnds_HIST2H2BE.md]]

           [[include:browser_HIST2H2BE.md]]

				HLA-A.md
			
          @@ -22,11 +22,11 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_HLA-A.md]]

          +[[include:tables/DLBCL_HLA-A.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_HLA-A.md]]

          +[[include:tables/dnds_HLA-A.md]]

           ## HLA-A Hotspots

				HLA-B.md
			
          @@ -22,12 +22,12 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_HLA-B.md]]

          -[[include:FL_HLA-B.md]]

          +[[include:tables/DLBCL_HLA-B.md]]

          +[[include:tables/FL_HLA-B.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_HLA-B.md]]

          +[[include:tables/dnds_HLA-B.md]]

           ## HLA-B Hotspots

				HLA-C.md
			
          @@ -23,11 +23,11 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_HLA-C.md]]

          +[[include:tables/DLBCL_HLA-C.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_HLA-C.md]]

          +[[include:tables/dnds_HLA-C.md]]

           [[include:browser_HLA-C.md]]

				HLA-DMA.md
			
          @@ -25,7 +25,7 @@ Mutations in this gene are relatively rare in DLBCL overall.

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_HLA-DMA.md]]

          +[[include:tables/dnds_HLA-DMA.md]]

				HLA-DMB.md
			
          @@ -19,11 +19,11 @@ Mutations in this gene were first described in DLBCL by [Hübschmann et al](pape

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_HLA-DMB.md]]

          +[[include:tables/DLBCL_HLA-DMB.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_HLA-DMB.md]]

          +[[include:tables/dnds_HLA-DMB.md]]

           [[include:browser_HLA-DMB.md]]

				HLA-DQA1.md
			
          @@ -28,7 +28,7 @@ Mutations in this gene were first described in DLBCL and FL in 2021 by Hübschma

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_HLA-DQA1.md]]

          +[[include:tables/dnds_HLA-DQA1.md]]

				HLA-DQB1.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_HLA-DQB1.md]]

          +[[include:tables/dnds_HLA-DQB1.md]]

				HNF1B.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_HNF1B.md]]

          +[[include:tables/dnds_HNF1B.md]]

				HNRNPH1.md
			
          @@ -30,7 +30,7 @@ The common HNRNPH1 mutations cause deregulated splicing and increased expression

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_HNRNPH1.md]]

          +[[include:tables/dnds_HNRNPH1.md]]

           ## HNRNPH1 Hotspots

				HNRNPU.md
			
          @@ -16,12 +16,12 @@ nocite: |

           ## Mutation incidence

          -[[include:DLBCL_HNRNPU.md]]

          -[[include:BL_HNRNPU.md]]

          +[[include:tables/DLBCL_HNRNPU.md]]

          +[[include:tables/BL_HNRNPU.md]]

           ## Mutation pattern

          -[[include:dnds_HNRNPU.md]]

          +[[include:tables/dnds_HNRNPU.md]]

           ## aSHM regions

				HRAS.md
			
          @@ -28,7 +28,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_HRAS.md]]

          +[[include:tables/dnds_HRAS.md]]

				HVCN1.md
			
          @@ -17,12 +17,12 @@ HVCN1, a voltage-gated proton channel, has been identified as recurrently mutate

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_HVCN1.md]]

          -[[include:FL_HVCN1.md]]

          +[[include:tables/DLBCL_HVCN1.md]]

          +[[include:tables/FL_HVCN1.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_HVCN1.md]]

          +[[include:tables/dnds_HVCN1.md]]

           ## HVCN1 Hotspots

				ID3.md
			
          @@ -19,12 +19,12 @@ The existence of mutations in DLBCL were described in 2012 by Schmitz et al[@sch

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_ID3.md]]

          -[[include:BL_ID3.md]]

          +[[include:tables/DLBCL_ID3.md]]

          +[[include:tables/BL_ID3.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ID3.md]]

          +[[include:tables/dnds_ID3.md]]

           ## aSHM regions

				IER2.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_IER2.md]]

          +[[include:tables/dnds_IER2.md]]

           ## IER2 Expression

				IFNGR1.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_IFNGR1.md]]

          +[[include:tables/dnds_IFNGR1.md]]

				IGLL5.md
			
          @@ -14,13 +14,13 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_IGLL5]]

          -[[include:BL_IGLL5]]

          -[[include:FL_IGLL5]]

          +[[include:tables/DLBCL_IGLL5]]

          +[[include:tables/BL_IGLL5]]

          +[[include:tables/FL_IGLL5]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_IGLL5.md]]

          +[[include:tables/dnds_IGLL5.md]]

           ## aSHM regions

				IKBKB.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_IKBKB.md]]

          +[[include:tables/dnds_IKBKB.md]]

				IKBKE.md
			
          @@ -27,7 +27,7 @@ Mutations in this gene were first described in DLBCL and FL in 2021 by Hübschma

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_IKBKE.md]]

          +[[include:tables/dnds_IKBKE.md]]

				IKZF3.md
			
          @@ -21,12 +21,12 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_IKZF3.md]]

          -[[include:BL_IKZF3.md]]

          +[[include:tables/DLBCL_IKZF3.md]]

          +[[include:tables/BL_IKZF3.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_IKZF3.md]]

          +[[include:tables/dnds_IKZF3.md]]

           ## aSHM regions

				IL16.md
			
          @@ -25,7 +25,7 @@ The IL16 gene, which encodes a pro-inflammatory cytokine, plays a role in immune

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_IL16.md]]

          +[[include:tables/dnds_IL16.md]]

				IL4R.md
			
          @@ -21,11 +21,11 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_IL4R.md]]

          +[[include:tables/DLBCL_IL4R.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_IL4R.md]]

          +[[include:tables/dnds_IL4R.md]]

           ## aSHM regions

				IL6.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_IL6.md]]

          +[[include:tables/dnds_IL6.md]]

				INO80.md
			
          @@ -27,7 +27,7 @@ Mutations in this gene were first described in DLBCL in 2013[@zhangGeneticHetero

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_INO80.md]]

          +[[include:tables/dnds_INO80.md]]

				IRF1.md
			
          @@ -27,7 +27,7 @@ Mutations in this gene were first described in DLBCL and FL in 2021 by Hübschma

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_IRF1.md]]

          +[[include:tables/dnds_IRF1.md]]

           ## aSHM regions

				IRF4.md
			
          @@ -20,12 +20,12 @@ There are a few mutation hotspots in this gene. The functional role of mutations

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_IRF4.md]]

          -[[include:FL_IRF4.md]]

          +[[include:tables/DLBCL_IRF4.md]]

          +[[include:tables/FL_IRF4.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_IRF4.md]]

          +[[include:tables/dnds_IRF4.md]]

           ## aSHM regions

				IRF8.md
			
          @@ -25,13 +25,13 @@ Driver mutations affecting this gene in DLBCL/FL have been experimentally demons

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_IRF8.md]]

          -[[include:FL_IRF8.md]]

          -[[include:BL_IRF8.md]]

          +[[include:tables/DLBCL_IRF8.md]]

          +[[include:tables/FL_IRF8.md]]

          +[[include:tables/BL_IRF8.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_IRF8.md]]

          +[[include:tables/dnds_IRF8.md]]

           ## aSHM regions

				ITPKB.md
			
          @@ -21,12 +21,12 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_ITPKB.md]]

          -[[include:FL_ITPKB.md]]

          +[[include:tables/DLBCL_ITPKB.md]]

          +[[include:tables/FL_ITPKB.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ITPKB.md]]

          +[[include:tables/dnds_ITPKB.md]]

           ## aSHM regions

				ITPR3.md
			
          @@ -27,7 +27,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ITPR3.md]]

          +[[include:tables/dnds_ITPR3.md]]

				JAK1.md
			
          @@ -28,7 +28,7 @@ Mutations in this gene were first described in DLBCL in 2013[@zhangGeneticHetero

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_JAK1.md]]

          +[[include:tables/dnds_JAK1.md]]

				JAK3.md
			
          @@ -28,7 +28,7 @@ Mutations in this gene were first described in DLBCL in 2013[@zhangGeneticHetero

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_JAK3.md]]

          +[[include:tables/dnds_JAK3.md]]

				JUNB.md
			
          @@ -25,12 +25,12 @@ Mutations in this gene were reported to be inflated in the original results acco

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_JUNB.md]]

          +[[include:tables/DLBCL_JUNB.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_JUNB.md]]

          +[[include:tables/dnds_JUNB.md]]

				JUP.md
			
          @@ -24,7 +24,7 @@ Mutations in this gene were first described in FL in 2021 by Hübschmann et al.[

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_JUP.md]]

          +[[include:tables/dnds_JUP.md]]

           [[include:browser_JUP.md]]

				KCMF1.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_KCMF1.md]]

          +[[include:tables/dnds_KCMF1.md]]

				KCNK10.md
			
          @@ -30,7 +30,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_KCNK10.md]]

          +[[include:tables/dnds_KCNK10.md]]

				KIFC3.md
			
          @@ -30,7 +30,7 @@ Due to [minimal support](KIFC3#representative-mutations) in the original primary

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_KIFC3.md]]

          +[[include:tables/dnds_KIFC3.md]]

				KIR3DL1.md
			
          @@ -20,7 +20,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_KIR3DL1.md]]

          +[[include:tables/dnds_KIR3DL1.md]]

				KLF2.md
			
          @@ -20,12 +20,12 @@ Contradictory to this, the mutation pattern in DLBCL implies selective pressure 

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_KLF2.md]]

          -[[include:FL_KLF2.md]]

          +[[include:tables/DLBCL_KLF2.md]]

          +[[include:tables/FL_KLF2.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_KLF2.md]]

          +[[include:tables/dnds_KLF2.md]]

           ## aSHM regions

				KLHL14.md
			
          @@ -21,11 +21,11 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_KLHL14.md]]

          +[[include:tables/DLBCL_KLHL14.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_KLHL14.md]]

          +[[include:tables/dnds_KLHL14.md]]

           ## Expression

           ![](images/gene_expression/KLHL14_by_pathology.svg)

				KLHL21.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_KLHL21.md]]

          +[[include:tables/dnds_KLHL21.md]]

           ## aSHM regions

				KLHL26.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_KLHL26.md]]

          +[[include:tables/dnds_KLHL26.md]]

				KLHL6.md
			
          @@ -22,12 +22,12 @@ Driver mutations affecting this gene in DLBCL/FL have been experimentally demons

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_KLHL6.md]]

          -[[include:FL_KLHL6.md]]

          +[[include:tables/DLBCL_KLHL6.md]]

          +[[include:tables/FL_KLHL6.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_KLHL6.md]]

          +[[include:tables/dnds_KLHL6.md]]

           ## aSHM regions

				KMT2C.md
			
          @@ -18,12 +18,12 @@ This gene has been reported to be recurrently mutated in DLBCL. The rate of muta

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_KMT2C.md]]

          -[[include:BL_KMT2C.md]]

          +[[include:tables/DLBCL_KMT2C.md]]

          +[[include:tables/BL_KMT2C.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_KMT2C.md]]

          +[[include:tables/dnds_KMT2C.md]]

           [[include:browser_KMT2C.md]]

				KMT2D.md
			
          @@ -27,13 +27,13 @@ Driver mutations affecting this gene in BL/DLBCL/FL have been experimentally dem

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_KMT2D.md]]

          -[[include:FL_KMT2D.md]]

          -[[include:BL_KMT2D.md]]

          +[[include:tables/DLBCL_KMT2D.md]]

          +[[include:tables/FL_KMT2D.md]]

          +[[include:tables/BL_KMT2D.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_KMT2D.md]]

          +[[include:tables/dnds_KMT2D.md]]

           [[include:browser_KMT2D.md]]

				KRAS.md
			
          @@ -21,11 +21,11 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_KRAS.md]]

          +[[include:tables/DLBCL_KRAS.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_KRAS.md]]

          +[[include:tables/dnds_KRAS.md]]

           ## KRAS Hotspots

				LAMA5.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_LAMA5.md]]

          +[[include:tables/dnds_LAMA5.md]]

				LAPTM5.md
			
          @@ -28,7 +28,7 @@ Mutations in this gene were first described in DLBCL and FL in 2021 by [Hübschm

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_LAPTM5.md]]

          +[[include:tables/dnds_LAPTM5.md]]

           ## aSHM regions

				LCOR.md
			
          @@ -29,7 +29,7 @@ LCOR (Ligand Dependent Nuclear Receptor Corepressor) is involved in the regulati

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_LCOR.md]]

          +[[include:tables/dnds_LCOR.md]]

				LIN54.md
			
          @@ -28,7 +28,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_LIN54.md]]

          +[[include:tables/dnds_LIN54.md]]

				LPP.md
			
          @@ -24,7 +24,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_LPP.md]]

          +[[include:tables/dnds_LPP.md]]

           ## aSHM regions

				LRP12.md
			
          @@ -28,7 +28,7 @@ Mutations in this gene were first described in DLBCL in 2021 by Hübschmann et a

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_LRP12.md]]

          +[[include:tables/dnds_LRP12.md]]

				LRRN3.md
			
          @@ -14,11 +14,11 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_LRRN3.md]]

          +[[include:tables/DLBCL_LRRN3.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_LRRN3.md]]

          +[[include:tables/dnds_LRRN3.md]]

           [[include:browser_LRRN3.md]]

				LTB.md
			
          @@ -17,13 +17,13 @@ LTB (Lymphotoxin Beta) is a member of the tumor necrosis factor (TNF) superfamil

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_LTB.md]]

          -[[include:FL_LTB.md]]

          -[[include:BL_LTB.md]]

          +[[include:tables/DLBCL_LTB.md]]

          +[[include:tables/FL_LTB.md]]

          +[[include:tables/BL_LTB.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_LTB.md]]

          +[[include:tables/dnds_LTB.md]]

           ## aSHM regions

				LYN.md
			
          @@ -25,7 +25,7 @@ LYN mutations have been reported in DLBCL but the rate is relatively rare in mos

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_LYN.md]]

          +[[include:tables/dnds_LYN.md]]

				MAGEC1.md
			
          @@ -20,7 +20,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_MAGEC1.md]]

          +[[include:tables/dnds_MAGEC1.md]]

				MAGT1.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_MAGT1.md]]

          +[[include:tables/dnds_MAGT1.md]]

				MAP2K1.md
			
          @@ -18,12 +18,12 @@ Driver mutations affecting this gene in FL have been experimentally demonstrated

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_MAP2K1.md]]

          -[[include:FL_MAP2K1.md]]

          +[[include:tables/DLBCL_MAP2K1.md]]

          +[[include:tables/FL_MAP2K1.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_MAP2K1.md]]

          +[[include:tables/dnds_MAP2K1.md]]

           ## MAP2K1 Hotspots

				MAP3K6.md
			
          @@ -27,7 +27,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_MAP3K6.md]]

          +[[include:tables/dnds_MAP3K6.md]]

				MAP4K4.md
			
          @@ -28,7 +28,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_MAP4K4.md]]

          +[[include:tables/dnds_MAP4K4.md]]

				MAP7D1.md
			
          @@ -20,7 +20,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_MAP7D1.md]]

          +[[include:tables/dnds_MAP7D1.md]]

				MARK1.md
			
          @@ -29,7 +29,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_MARK1.md]]

          +[[include:tables/dnds_MARK1.md]]

				MCL1.md
			
          @@ -31,7 +31,7 @@ MCL1 is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm) 

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_MCL1.md]]

          +[[include:tables/dnds_MCL1.md]]

           ## aSHM regions

				MECOM.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_MECOM.md]]

          +[[include:tables/dnds_MECOM.md]]

				MEF2B.md
			
          @@ -21,12 +21,12 @@ Thus far, there is limited information about the consequence of MEF2B mutations 

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_MEF2B.md]]

          -[[include:FL_MEF2B.md]]

          +[[include:tables/DLBCL_MEF2B.md]]

          +[[include:tables/FL_MEF2B.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_MEF2B.md]]

          +[[include:tables/dnds_MEF2B.md]]

           ## aSHM regions

				MEF2C.md
			
          @@ -19,13 +19,13 @@ Mutations in this gene were first described in DLBCL by [Arthur et al](papers/ar

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_MEF2C.md]]

          -[[include:DLBCL_MEF2C.md]]

          +[[include:tables/DLBCL_MEF2C.md]]

          +[[include:tables/DLBCL_MEF2C.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_MEF2C.md]]

          +[[include:tables/dnds_MEF2C.md]]

           ## aSHM regions

				MET.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_MET.md]]

          +[[include:tables/dnds_MET.md]]

				MGA.md
			
          @@ -21,11 +21,11 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_MGA.md]]

          +[[include:tables/DLBCL_MGA.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_MGA.md]]

          +[[include:tables/dnds_MGA.md]]

           [[include:browser_MGA.md]]

				MIR155HG.md
			
          @@ -11,7 +11,7 @@ nocite: |

           |Entity|Tier|Description                              |

           |:------:|:----:|-----------------------------------------|

          -|![DLBCL](images/icons/DLBCL_tier2.png) |2-a | aSHM target; Although recurrent, the relevance of mutations in DLBCL is tenuous |

          +|![DLBCL](images/icons/tables/DLBCL_tier2.png) |2-a | aSHM target; Although recurrent, the relevance of mutations in DLBCL is tenuous |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

				MKI67.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_MKI67.md]]

          +[[include:tables/dnds_MKI67.md]]

				MME.md
			
          @@ -30,7 +30,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_MME.md]]

          +[[include:tables/dnds_MME.md]]

				MPDZ.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_MPDZ.md]]

          +[[include:tables/dnds_MPDZ.md]]

				MPEG1.md
			
          @@ -17,11 +17,11 @@ Mutations in MPEG1 have been described in DLBCL[@morinMutationalStructuralAnalys

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_MPEG1.md]]

          +[[include:tables/DLBCL_MPEG1.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_MPEG1.md]]

          +[[include:tables/dnds_MPEG1.md]]

           [[include:browser_MPEG1.md]]

				MS4A1.md
			
          @@ -24,11 +24,11 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_MS4A1.md]]

          +[[include:tables/DLBCL_MS4A1.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_MS4A1.md]]

          +[[include:tables/dnds_MS4A1.md]]

           ## aSHM regions

				MSH2.md
			
          @@ -28,7 +28,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_MSH2.md]]

          +[[include:tables/dnds_MSH2.md]]

				MSH6.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_MSH6.md]]

          +[[include:tables/dnds_MSH6.md]]

				MTOR.md
			
          @@ -28,12 +28,12 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_MTOR.md]]

          -[[include:BL_MTOR.md]]

          +[[include:tables/DLBCL_MTOR.md]]

          +[[include:tables/BL_MTOR.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_MTOR.md]]

          +[[include:tables/dnds_MTOR.md]]

				MYB.md
			
          @@ -28,7 +28,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_MYB.md]]

          +[[include:tables/dnds_MYB.md]]

				MYBPC2.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_MYBPC2.md]]

          +[[include:tables/dnds_MYBPC2.md]]

				MYC.md
			
          @@ -21,13 +21,13 @@ Driver mutations affecting this gene in DLBCL/FL/BL have been experimentally dem

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_MYC.md]]

          -[[include:FL_MYC.md]]

          -[[include:BL_MYC.md]]

          +[[include:tables/DLBCL_MYC.md]]

          +[[include:tables/FL_MYC.md]]

          +[[include:tables/BL_MYC.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_MYC.md]]

          +[[include:tables/dnds_MYC.md]]

           ## aSHM regions

				MYCBP2.md
			
          @@ -24,7 +24,7 @@ Mutations in this gene were first described in FL in 2021 by Hübschmann et al.[

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_MYCBP2.md]]

          +[[include:tables/dnds_MYCBP2.md]]

           [[include:browser_MYCBP2.md]]

				MYD88.md
			
          @@ -18,12 +18,12 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_MYD88.md]]

          -[[include:FL_MYD88.md]]

          +[[include:tables/DLBCL_MYD88.md]]

          +[[include:tables/FL_MYD88.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_MYD88.md]]

          +[[include:tables/dnds_MYD88.md]]

           ## MYD88 Hotspots

				MYH10.md
			
          @@ -27,7 +27,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_MYH10.md]]

          +[[include:tables/dnds_MYH10.md]]

				MYO18A.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_MYO18A.md]]

          +[[include:tables/dnds_MYO18A.md]]

				MYO1E.md
			
          @@ -11,7 +11,7 @@ nocite: |

           |Entity|Tier|Description                              |

           |:------:|:----:|-----------------------------------------|

          -|![DLBCL](images/icons/DLBCL_tier2.png) |2-a | aSHM target; Although recurrent, the relevance of mutations in DLBCL is tenuous |

          +|![DLBCL](images/icons/tables/DLBCL_tier2.png) |2-a | aSHM target; Although recurrent, the relevance of mutations in DLBCL is tenuous |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

				MYOM2.md
			
          @@ -26,7 +26,7 @@ The prevalence of MYOM2 mutations in DLBCL varies across studies. The role of th

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_MYOM2.md]]

          +[[include:tables/dnds_MYOM2.md]]

				N2RF2.md
			
          @@ -15,7 +15,7 @@ nocite: |

           |Entity|Tier|Description|

           |:------:|:----:|--------------------------------------|

          -|![DLBCL](images/icons/DLBCL_tier2.png)|2|relevance in DLBCL not firmly established[@hubschmannMutationalMechanismsShaping2021]|

          +|![DLBCL](images/icons/tables/DLBCL_tier2.png)|2|relevance in DLBCL not firmly established[@hubschmannMutationalMechanismsShaping2021]|

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

				NANOG.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_NANOG.md]]

          +[[include:tables/dnds_NANOG.md]]

				NAV1.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_NAV1.md]]

          +[[include:tables/dnds_NAV1.md]]

				NBEAL1.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_NBEAL1.md]]

          +[[include:tables/dnds_NBEAL1.md]]

				NCOA3.md
			
          @@ -11,7 +11,7 @@ nocite: |

           |Entity|Tier|Description                              |

           |:------:|:----:|-----------------------------------------|

          -|![DLBCL](images/icons/DLBCL_tier2.png) |2-a | aSHM target; Although recurrent, the relevance of mutations in DLBCL is tenuous |

          +|![DLBCL](images/icons/tables/DLBCL_tier2.png) |2-a | aSHM target; Although recurrent, the relevance of mutations in DLBCL is tenuous |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

				NCOR1.md
			
          @@ -28,7 +28,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_NCOR1.md]]

          +[[include:tables/dnds_NCOR1.md]]

				NCOR2.md
			
          @@ -29,7 +29,7 @@ Mutations in this gene are relatively rare in DLBCL overall but show a pattern o

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_NCOR2.md]]

          +[[include:tables/dnds_NCOR2.md]]

				NF1.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_NF1.md]]

          +[[include:tables/dnds_NF1.md]]

				NFKB1.md
			
          @@ -14,7 +14,7 @@ Mutations in this gene are relatively rare in DLBCL overall. Some hotspots have 

           |Entity|Tier|Description               |

           |:------:|:----:|--------------------------|

          -|![DLBCL](images/icons/DLBCL_tier1.png) |2   |low-confidence DLBCL gene|

          +|![DLBCL](images/icons/tables/DLBCL_tier1.png) |2   |low-confidence DLBCL gene|

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

				NFKB2.md
			
          @@ -28,7 +28,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_NFKB2.md]]

          +[[include:tables/dnds_NFKB2.md]]

				NFKBIA.md
			
          @@ -21,12 +21,12 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_NFKBIA.md]]

          -[[include:FL_NFKBIA.md]]

          +[[include:tables/DLBCL_NFKBIA.md]]

          +[[include:tables/FL_NFKBIA.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_NFKBIA.md]]

          +[[include:tables/dnds_NFKBIA.md]]

           [[include:browser_NFKBIA.md]]

				NFKBIE.md
			
          @@ -23,11 +23,11 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_NFKBIE.md]]

          +[[include:tables/DLBCL_NFKBIE.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_NFKBIE.md]]

          +[[include:tables/dnds_NFKBIE.md]]

           [[include:browser_NFKBIE.md]]

				NFKBIZ.md
			
          @@ -21,11 +21,11 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_NFKBIZ.md]]

          +[[include:tables/DLBCL_NFKBIZ.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_NFKBIZ.md]]

          +[[include:tables/dnds_NFKBIZ.md]]

           ## aSHM regions

				NLRC5.md
			
          @@ -11,7 +11,7 @@ nocite: |

           |Entity|Tier|Description               |

           |:------:|:----:|--------------------------|

          -|![DLBCL](images/icons/DLBCL_tier1.png) |1   |high-confidence DLBCL gene|

          +|![DLBCL](images/icons/tables/DLBCL_tier1.png) |1   |high-confidence DLBCL gene|

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

				NLRP5.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_NLRP5.md]]

          +[[include:tables/dnds_NLRP5.md]]

				NLRP8.md
			
          @@ -24,7 +24,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_NLRP8.md]]

          +[[include:tables/dnds_NLRP8.md]]

           [[include:browser_NLRP8.md]]

				NOA1.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_NOA1.md]]

          +[[include:tables/dnds_NOA1.md]]

           [[include:browser_NOA1.md]]

				NOL9.md
			
          @@ -14,11 +14,11 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_NOL9.md]]

          +[[include:tables/DLBCL_NOL9.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_NOL9.md]]

          +[[include:tables/dnds_NOL9.md]]

           ## NOL9 Hotspots

				NOTCH1.md
			
          @@ -27,12 +27,12 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_NOTCH1.md]]

          -[[include:BL_NOTCH1.md]]

          +[[include:tables/DLBCL_NOTCH1.md]]

          +[[include:tables/BL_NOTCH1.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_NOTCH1.md]]

          +[[include:tables/dnds_NOTCH1.md]]

           ## NOTCH1 Hotspots

				NOTCH2.md
			
          @@ -20,11 +20,11 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_NOTCH2.md]]

          +[[include:tables/DLBCL_NOTCH2.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_NOTCH2.md]]

          +[[include:tables/dnds_NOTCH2.md]]

           ## NOTCH2 Hotspots

				NRXN2.md
			
          @@ -27,7 +27,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_NRXN2.md]]

          +[[include:tables/dnds_NRXN2.md]]

           [[include:browser_NRXN2.md]]

				OR8H2.md
			
          @@ -20,7 +20,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_OR8H2.md]]

          +[[include:tables/dnds_OR8H2.md]]

				OSBPL10.md
			
          @@ -17,11 +17,11 @@ OSBPL10 is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ash

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_OSBPL10.md]]

          +[[include:tables/DLBCL_OSBPL10.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_OSBPL10.md]]

          +[[include:tables/dnds_OSBPL10.md]]

           ## aSHM regions

				P2RX5.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_P2RX5.md]]

          +[[include:tables/dnds_P2RX5.md]]

           ## aSHM regions

				P2RY2.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_P2RY2.md]]

          +[[include:tables/dnds_P2RY2.md]]

				P2RY8.md
			
          @@ -23,12 +23,12 @@ Driver mutations affecting this gene in BL/DLBCL have been experimentally demons

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_P2RY8.md]]

          -[[include:BL_P2RY8.md]]

          +[[include:tables/DLBCL_P2RY8.md]]

          +[[include:tables/BL_P2RY8.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_P2RY8.md]]

          +[[include:tables/dnds_P2RY8.md]]

           [[include:browser_P2RY8.md]]

				PABPC4L.md
			
          @@ -30,7 +30,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PABPC4L.md]]

          +[[include:tables/dnds_PABPC4L.md]]

				PAPOLG.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PAPOLG.md]]

          +[[include:tables/dnds_PAPOLG.md]]

				PASK.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PASK.md]]

          +[[include:tables/dnds_PASK.md]]

				PAX5.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PAX5.md]]

          +[[include:tables/dnds_PAX5.md]]

           ## aSHM regions

				PC.md
			
          @@ -29,7 +29,7 @@ Due to [minimal support](PC#representative-mutations) in the original primary da

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PC.md]]

          +[[include:tables/dnds_PC.md]]

           [[include:browser_PC.md]]

				PCBP1.md
			
          @@ -15,12 +15,12 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_PCBP1.md]]

          -[[include:BL_PCBP1.md]]

          +[[include:tables/DLBCL_PCBP1.md]]

          +[[include:tables/BL_PCBP1.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PCBP1.md]]

          +[[include:tables/dnds_PCBP1.md]]

           ## PCBP1 Hotspots

				PCDHA11.md
			
          @@ -30,7 +30,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PCDHA11.md]]

          +[[include:tables/dnds_PCDHA11.md]]

				PCDHB11.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PCDHB11.md]]

          +[[include:tables/dnds_PCDHB11.md]]

           [[include:browser_PCDHB11.md]]

				PCLO.md
			
          @@ -24,7 +24,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PCLO.md]]

          +[[include:tables/dnds_PCLO.md]]

           ## PCLO Hotspots

				PDCD11.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PDCD11.md]]

          +[[include:tables/dnds_PDCD11.md]]

				PDE4DIP.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PDE4DIP.md]]

          +[[include:tables/dnds_PDE4DIP.md]]

           [[include:browser_PDE4DIP.md]]

				PDS5B.md
			
          @@ -26,7 +26,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PDS5B.md]]

          +[[include:tables/dnds_PDS5B.md]]

           [[include:browser_PDS5B.md]]

				PDZRN3.md
			
          @@ -30,7 +30,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PDZRN3.md]]

          +[[include:tables/dnds_PDZRN3.md]]

				PHF6.md
			
          @@ -15,12 +15,12 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_PHF6.md]]

          -[[include:BL_PHF6.md]]

          +[[include:tables/DLBCL_PHF6.md]]

          +[[include:tables/BL_PHF6.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PHF6.md]]

          +[[include:tables/dnds_PHF6.md]]

           [[include:browser_PHF6.md]]

				PIK3CD.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PIK3CD.md]]

          +[[include:tables/dnds_PIK3CD.md]]

				PIK3R1.md
			
          @@ -36,7 +36,7 @@ Mutations in this gene were first described in DLBCL in 2013[@zhangGeneticHetero

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PIK3R1.md]]

          +[[include:tables/dnds_PIK3R1.md]]

				PIM1.md
			
          @@ -25,13 +25,13 @@ Driver mutations affecting this gene in FL/DLBCL have been experimentally demons

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_PIM1.md]]

          -[[include:FL_PIM1.md]]

          -[[include:BL_PIM1.md]]

          +[[include:tables/DLBCL_PIM1.md]]

          +[[include:tables/FL_PIM1.md]]

          +[[include:tables/BL_PIM1.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PIM1.md]]

          +[[include:tables/dnds_PIM1.md]]

           ## aSHM regions

				PIM2.md
			
          @@ -18,11 +18,11 @@ PIM2 is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm) 

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_PIM2.md]]

          +[[include:tables/DLBCL_PIM2.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PIM2.md]]

          +[[include:tables/dnds_PIM2.md]]

           ## aSHM regions

				PKD1.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PKD1.md]]

          +[[include:tables/dnds_PKD1.md]]

				PLCG2.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PLCG2.md]]

          +[[include:tables/dnds_PLCG2.md]]

				PNPO.md
			
          @@ -27,7 +27,7 @@ Mutations in this gene were first described in DLBCL and FL in 2021 by Hübschma

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PNPO.md]]

          +[[include:tables/dnds_PNPO.md]]

           [[include:browser_PNPO.md]]

				POGZ.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_POGZ.md]]

          +[[include:tables/dnds_POGZ.md]]

				POLRMT.md
			
          @@ -27,7 +27,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_POLRMT.md]]

          +[[include:tables/dnds_POLRMT.md]]

           [[include:browser_POLRMT.md]]

				POR.md
			
          @@ -27,7 +27,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_POR.md]]

          +[[include:tables/dnds_POR.md]]

				POU2AF1.md
			
          @@ -22,12 +22,12 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_POU2AF1.md]]

          -[[include:FL_POU2AF1.md]]

          +[[include:tables/DLBCL_POU2AF1.md]]

          +[[include:tables/FL_POU2AF1.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_POU2AF1.md]]

          +[[include:tables/dnds_POU2AF1.md]]

           ## aSHM regions

				POU2F2.md
			
          @@ -18,12 +18,12 @@ Driver mutations affecting this gene in FL/DLBCL have been experimentally demons

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_POU2F2.md]]

          -[[include:FL_POU2F2.md]]

          +[[include:tables/DLBCL_POU2F2.md]]

          +[[include:tables/FL_POU2F2.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_POU2F2.md]]

          +[[include:tables/dnds_POU2F2.md]]

           ## POU2F2 Hotspots

				PPP1R9B.md
			
          @@ -11,7 +11,7 @@ nocite: |

           |Entity|Tier|Description               |

           |:------:|:----:|--------------------------|

          -|![DLBCL](images/icons/DLBCL_tier2.png) | 2   | low-confidence DLBCL gene|

          +|![DLBCL](images/icons/tables/DLBCL_tier2.png) | 2   | low-confidence DLBCL gene|

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

				PPP4C.md
			
          @@ -20,7 +20,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PPP4C.md]]

          +[[include:tables/dnds_PPP4C.md]]

           ## PPP4C Hotspots

				PPP6R2.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PPP6R2.md]]

          +[[include:tables/dnds_PPP6R2.md]]

				PRDM1.md
			
          @@ -18,12 +18,12 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_PRDM1.md]]

          -[[include:BL_PRDM1.md]]

          +[[include:tables/DLBCL_PRDM1.md]]

          +[[include:tables/BL_PRDM1.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PRDM1.md]]

          +[[include:tables/dnds_PRDM1.md]]

           ## PRDM1 Hotspots

				PREX1.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PREX1.md]]

          +[[include:tables/dnds_PREX1.md]]

				PRKCB.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PRKCB.md]]

          +[[include:tables/dnds_PRKCB.md]]

				PRKDC.md
			
          @@ -24,7 +24,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PRKDC.md]]

          +[[include:tables/dnds_PRKDC.md]]

				PRPS1.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PRPS1.md]]

          +[[include:tables/dnds_PRPS1.md]]

				PRSS22.md
			
          @@ -31,7 +31,7 @@ Due to [minimal support](PRSS22#representative-mutation) in the original primary

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PRSS22.md]]

          +[[include:tables/dnds_PRSS22.md]]

				PTEN.md
			
          @@ -18,12 +18,12 @@ Driver mutations affecting this gene in BL/DLBCL have been experimentally demons

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_PTEN.md]]

          -[[include:BL_PTEN.md]]

          +[[include:tables/DLBCL_PTEN.md]]

          +[[include:tables/BL_PTEN.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PTEN.md]]

          +[[include:tables/dnds_PTEN.md]]

           [[include:browser_PTEN.md]]

				PTMA.md
			
          @@ -11,7 +11,7 @@ nocite: |

           |Entity|Tier|Description                              |

           |:------:|:----:|-----------------------------------------|

          -|![DLBCL](images/icons/DLBCL_tier2.png) |2-a | aSHM target; Although recurrent, the relevance of mutations in DLBCL is tenuous |

          +|![DLBCL](images/icons/tables/DLBCL_tier2.png) |2-a | aSHM target; Although recurrent, the relevance of mutations in DLBCL is tenuous |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

				PTPN23.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PTPN23.md]]

          +[[include:tables/dnds_PTPN23.md]]

				PTPN6.md
			
          @@ -18,11 +18,11 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_PTPN6.md]]

          +[[include:tables/DLBCL_PTPN6.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PTPN6.md]]

          +[[include:tables/dnds_PTPN6.md]]

           [[include:browser_PTPN6.md]]

				PTPRD.md
			
          @@ -24,7 +24,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PTPRD.md]]

          +[[include:tables/dnds_PTPRD.md]]

				PTPRK.md
			
          @@ -28,7 +28,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PTPRK.md]]

          +[[include:tables/dnds_PTPRK.md]]

				PTPRN.md
			
          @@ -27,7 +27,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PTPRN.md]]

          +[[include:tables/dnds_PTPRN.md]]

				PXDNL.md
			
          @@ -30,7 +30,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PXDNL.md]]

          +[[include:tables/dnds_PXDNL.md]]

				PZP.md
			
          @@ -20,7 +20,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_PZP.md]]

          +[[include:tables/dnds_PZP.md]]

				RAC2.md
			
          @@ -24,7 +24,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_RAC2.md]]

          +[[include:tables/dnds_RAC2.md]]

           ## RAC2 Hotspots

				RAD9A.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_RAD9A.md]]

          +[[include:tables/dnds_RAD9A.md]]

           [[include:browser_RAD9A.md]]

				RANBP6.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_RANBP6.md]]

          +[[include:tables/dnds_RANBP6.md]]

				RARA.md
			
          @@ -28,7 +28,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_RARA.md]]

          +[[include:tables/dnds_RARA.md]]

				RB1.md
			
          @@ -19,11 +19,11 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_RB1.md]]

          +[[include:tables/DLBCL_RB1.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_RB1.md]]

          +[[include:tables/dnds_RB1.md]]

           [[include:browser_RB1.md]]

				RBM6.md
			
          @@ -24,7 +24,7 @@ Mutations in this gene were first described in DLBCL and FL in 2021 by Hübschma

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_RBM6.md]]

          +[[include:tables/dnds_RBM6.md]]

           [[include:browser_RBM6.md]]

				RBP3.md
			
          @@ -27,7 +27,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_RBP3.md]]

          +[[include:tables/dnds_RBP3.md]]

				RET.md
			
          @@ -31,7 +31,7 @@ Due to [minimal support](RET#representative-mutation) in the original primary da

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_RET.md]]

          +[[include:tables/dnds_RET.md]]

				REV3L.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_REV3L.md]]

          +[[include:tables/dnds_REV3L.md]]

				RFTN1.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_RFTN1.md]]

          +[[include:tables/dnds_RFTN1.md]]

           ## aSHM regions

				RFX7.md
			
          @@ -22,12 +22,12 @@ Driver mutations affecting this gene in DLBCL/BL have been experimentally demons

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_RFX7.md]]

          -[[include:BL_RFX7.md]]

          +[[include:tables/DLBCL_RFX7.md]]

          +[[include:tables/BL_RFX7.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_RFX7.md]]

          +[[include:tables/dnds_RFX7.md]]

           [[include:browser_RFX7.md]]

				RFXAP.md
			
          @@ -11,7 +11,7 @@ nocite: |

           |Entity|Tier|Description               |

           |:------:|:----:|--------------------------|

          -|![DLBCL](images/icons/DLBCL_tier2.png) |2   |low-confidence DLBCL gene|

          +|![DLBCL](images/icons/tables/DLBCL_tier2.png) |2   |low-confidence DLBCL gene|

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

				RHOA.md
			
          @@ -18,12 +18,12 @@ Driver mutations affecting this gene in DLBCL/BL have been experimentally demons

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_RHOA.md]]

          -[[include:BL_RHOA.md]]

          +[[include:tables/DLBCL_RHOA.md]]

          +[[include:tables/BL_RHOA.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_RHOA.md]]

          +[[include:tables/dnds_RHOA.md]]

           ## RHOA Hotspots

				RHOH.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_RHOH.md]]

          +[[include:tables/dnds_RHOH.md]]

           ## aSHM regions

				RNF144B.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_RNF144B.md]]

          +[[include:tables/dnds_RNF144B.md]]

           ## aSHM regions

				RPL10.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_RPL10.md]]

          +[[include:tables/dnds_RPL10.md]]

				RRAGC.md
			
          @@ -18,12 +18,12 @@ Driver mutations affecting this gene in DLBCL/FL have been experimentally demons

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_RRAGC.md]]

          -[[include:FL_RRAGC.md]]

          +[[include:tables/DLBCL_RRAGC.md]]

          +[[include:tables/FL_RRAGC.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_RRAGC.md]]

          +[[include:tables/dnds_RRAGC.md]]

           [[include:browser_RRAGC.md]]

				RUBCNL.md
			
          @@ -11,7 +11,7 @@ nocite: |

           |Entity|Tier|Description                              |

           |:------:|:----:|-----------------------------------------|

          -|![DLBCL](images/icons/DLBCL_tier2.png) |2   |relevance in DLBCL not firmly established|

          +|![DLBCL](images/icons/tables/DLBCL_tier2.png) |2   |relevance in DLBCL not firmly established|

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

				RUNX1.md
			
          @@ -28,7 +28,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_RUNX1.md]]

          +[[include:tables/dnds_RUNX1.md]]

				S1PR1.md
			
          @@ -21,7 +21,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_S1PR1.md]]

          +[[include:tables/dnds_S1PR1.md]]

				S1PR2.md
			
          @@ -21,13 +21,13 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_S1PR2.md]]

          -[[include:FL_S1PR2.md]]

          -[[include:BL_S1PR2.md]]

          +[[include:tables/DLBCL_S1PR2.md]]

          +[[include:tables/FL_S1PR2.md]]

          +[[include:tables/BL_S1PR2.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_S1PR2.md]]

          +[[include:tables/dnds_S1PR2.md]]

           ## aSHM regions

				SALL3.md
			
          @@ -28,7 +28,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_SALL3.md]]

          +[[include:tables/dnds_SALL3.md]]

				SAMD9L.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_SAMD9L.md]]

          +[[include:tables/dnds_SAMD9L.md]]

				SARM1.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_SARM1.md]]

          +[[include:tables/dnds_SARM1.md]]

				SBF1.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_SBF1.md]]

          +[[include:tables/dnds_SBF1.md]]

				SEL1L3.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_SEL1L3.md]]

          +[[include:tables/dnds_SEL1L3.md]]

           ## aSHM regions

				SEPTIN9.md
			
          @@ -11,7 +11,7 @@ nocite: |

           |Entity|Tier|Description                              |

           |:------:|:----:|-----------------------------------------|

          -|![DLBCL](images/icons/DLBCL_tier2.png) |2   |relevance in DLBCL not firmly established|

          +|![DLBCL](images/icons/tables/DLBCL_tier2.png) |2   |relevance in DLBCL not firmly established|

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

				SERPINA9.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_SERPINA9.md]]

          +[[include:tables/dnds_SERPINA9.md]]

           ## aSHM regions

				SETD1B.md
			
          @@ -18,11 +18,11 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_SETD1B.md]]

          +[[include:tables/DLBCL_SETD1B.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_SETD1B.md]]

          +[[include:tables/dnds_SETD1B.md]]

           ## SETD1B Hotspots

				SETD2.md
			
          @@ -28,7 +28,7 @@ Mutations in this gene were first described in DLBCL in 2013[@zhangGeneticHetero

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_SETD2.md]]

          +[[include:tables/dnds_SETD2.md]]

				SETD5.md
			
          @@ -29,7 +29,7 @@ Mutations in this gene were reported to be inflated in the original results acco

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_SETD5.md]]

          +[[include:tables/dnds_SETD5.md]]

				SF3B1.md
			
          @@ -23,12 +23,12 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_SF3B1.md]]

          -[[include:BL_SF3B1.md]]

          +[[include:tables/DLBCL_SF3B1.md]]

          +[[include:tables/BL_SF3B1.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_SF3B1.md]]

          +[[include:tables/dnds_SF3B1.md]]

           ## SF3B1 Hotspots

				SGK1.md
			
          @@ -18,12 +18,12 @@ Driver mutations affecting this gene in FL/DLBCL have been experimentally demons

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_SGK1.md]]

          -[[include:FL_SGK1.md]]

          +[[include:tables/DLBCL_SGK1.md]]

          +[[include:tables/FL_SGK1.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_SGK1.md]]

          +[[include:tables/dnds_SGK1.md]]

           ## aSHM regions

				SHANK1.md
			
          @@ -27,7 +27,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_SHANK1.md]]

          +[[include:tables/dnds_SHANK1.md]]

				SHROOM3.md
			
          @@ -20,7 +20,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_SHROOM3.md]]

          +[[include:tables/dnds_SHROOM3.md]]

				SIAH2.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_SIAH2.md]]

          +[[include:tables/dnds_SIAH2.md]]

				SIN3A.md
			
          @@ -15,12 +15,12 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_SIN3A.md]]

          -[[include:BL_SIN3A.md]]

          +[[include:tables/DLBCL_SIN3A.md]]

          +[[include:tables/BL_SIN3A.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_SIN3A.md]]

          +[[include:tables/dnds_SIN3A.md]]

           [[include:browser_SIN3A.md]]

				SLC29A2.md
			
          @@ -27,7 +27,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_SLC29A2.md]]

          +[[include:tables/dnds_SLC29A2.md]]

				SLC34A2.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_SLC34A2.md]]

          +[[include:tables/dnds_SLC34A2.md]]

           [[include:browser_SLC34A2.md]]

				SMARCA4.md
			
          @@ -24,13 +24,13 @@ Driver mutations affecting this gene in DLBCL/FL/BL have been experimentally dem

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_SMARCA4.md]]

          -[[include:FL_SMARCA4.md]]

          -[[include:BL_SMARCA4.md]]

          +[[include:tables/DLBCL_SMARCA4.md]]

          +[[include:tables/FL_SMARCA4.md]]

          +[[include:tables/BL_SMARCA4.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_SMARCA4.md]]

          +[[include:tables/dnds_SMARCA4.md]]

           [[include:browser_SMARCA4.md]]

				SNTB2.md
			
          @@ -30,7 +30,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_SNTB2.md]]

          +[[include:tables/dnds_SNTB2.md]]

           [[include:browser_SNTB2.md]]

				SOCS1.md
			
          @@ -18,12 +18,12 @@ Driver mutations affecting this gene in FL/DLBCL have been experimentally demons

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_SOCS1.md]]

          -[[include:FL_SOCS1.md]]

          +[[include:tables/DLBCL_SOCS1.md]]

          +[[include:tables/FL_SOCS1.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_SOCS1.md]]

          +[[include:tables/dnds_SOCS1.md]]

           ## aSHM regions

				SPEN.md
			
          @@ -15,11 +15,11 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_SPEN.md]]

          +[[include:tables/DLBCL_SPEN.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_SPEN.md]]

          +[[include:tables/dnds_SPEN.md]]

           ## SPEN Hotspots

				SRRM2.md
			
          @@ -24,7 +24,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_SRRM2.md]]

          +[[include:tables/dnds_SRRM2.md]]

				ST6GAL1.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ST6GAL1.md]]

          +[[include:tables/dnds_ST6GAL1.md]]

           ## aSHM regions

				STAB2.md
			
          @@ -20,7 +20,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_STAB2.md]]

          +[[include:tables/dnds_STAB2.md]]

				STAT3.md
			
          @@ -20,11 +20,11 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_STAT3.md]]

          +[[include:tables/DLBCL_STAT3.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_STAT3.md]]

          +[[include:tables/dnds_STAT3.md]]

           ## STAT3 Hotspots

				STAT5B.md
			
          @@ -28,7 +28,7 @@ Mutations in this gene were first described in DLBCL in 2013[@zhangGeneticHetero

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_STAT5B.md]]

          +[[include:tables/dnds_STAT5B.md]]

				STAT6.md
			
          @@ -23,12 +23,12 @@ Driver mutations affecting this gene in DLBCL/FL have been experimentally demons

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_STAT6.md]]

          -[[include:FL_STAT6.md]]

          +[[include:tables/DLBCL_STAT6.md]]

          +[[include:tables/FL_STAT6.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_STAT6.md]]

          +[[include:tables/dnds_STAT6.md]]

           ## STAT6 Hotspots

				SYK.md
			
          @@ -28,7 +28,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_SYK.md]]

          +[[include:tables/dnds_SYK.md]]

				SYNGAP1.md
			
          @@ -31,7 +31,7 @@ Due to [minimal support](SYNGAP1#representative-mutation) in the original primar

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_SYNGAP1.md]]

          +[[include:tables/dnds_SYNGAP1.md]]

           [[include:browser_SYNGAP1.md]]

				SYPL1.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_SYPL1.md]]

          +[[include:tables/dnds_SYPL1.md]]

				TAF1.md
			
          @@ -14,11 +14,11 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_TAF1.md]]

          +[[include:tables/DLBCL_TAF1.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_TAF1.md]]

          +[[include:tables/dnds_TAF1.md]]

           [[include:browser_TAF1.md]]

				TAP1.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_TAP1.md]]

          +[[include:tables/dnds_TAP1.md]]

           [[include:browser_TAP1.md]]

				TBC1D4.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_TBC1D4.md]]

          +[[include:tables/dnds_TBC1D4.md]]

           ## aSHM regions

				TBC1D9B.md
			
          @@ -27,7 +27,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_TBC1D9B.md]]

          +[[include:tables/dnds_TBC1D9B.md]]

           [[include:browser_TBC1D9B.md]]

				TBL1XR1.md
			
          @@ -18,12 +18,12 @@ Driver mutations affecting this gene in FL/DLBCL have been experimentally demons

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_TBL1XR1.md]]

          -[[include:FL_TBL1XR1.md]]

          +[[include:tables/DLBCL_TBL1XR1.md]]

          +[[include:tables/FL_TBL1XR1.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_TBL1XR1.md]]

          +[[include:tables/dnds_TBL1XR1.md]]

           ## TBL1XR1 Hotspots

				TCF3.md
			
          @@ -19,12 +19,12 @@ Driver mutations affecting this gene in BL have been experimentally demonstrated

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_TCF3.md]]

          -[[include:BL_TCF3.md]]

          +[[include:tables/DLBCL_TCF3.md]]

          +[[include:tables/BL_TCF3.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_TCF3.md]]

          +[[include:tables/dnds_TCF3.md]]

           ## TCF3 Hotspots

				TCL1A.md
			
          @@ -15,12 +15,12 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_TCL1A.md]]

          -[[include:BL_TCL1A.md]]

          +[[include:tables/DLBCL_TCL1A.md]]

          +[[include:tables/BL_TCL1A.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_TCL1A.md]]

          +[[include:tables/dnds_TCL1A.md]]

           ## aSHM regions

				TET2.md
			
          @@ -19,11 +19,11 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_TET2.md]]

          +[[include:tables/DLBCL_TET2.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_TET2.md]]

          +[[include:tables/dnds_TET2.md]]

           [[include:browser_TET2.md]]

				TFAP4.md
			
          @@ -22,12 +22,12 @@ Driver mutations affecting this gene in BL have been experimentally demonstrated

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_TFAP4.md]]

          -[[include:BL_TFAP4.md]]

          +[[include:tables/DLBCL_TFAP4.md]]

          +[[include:tables/BL_TFAP4.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_TFAP4.md]]

          +[[include:tables/dnds_TFAP4.md]]

           [[include:browser_TFAP4.md]]

				TGFBR2.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_TGFBR2.md]]

          +[[include:tables/dnds_TGFBR2.md]]

				TIGD6.md
			
          @@ -27,7 +27,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_TIGD6.md]]

          +[[include:tables/dnds_TIGD6.md]]

				TIPARP.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_TIPARP.md]]

          +[[include:tables/dnds_TIPARP.md]]

				TLR2.md
			
          @@ -24,7 +24,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_TLR2.md]]

          +[[include:tables/dnds_TLR2.md]]

           ## TLR2 Hotspots

				TMEM30A.md
			
          @@ -18,12 +18,12 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_TMEM30A.md]]

          -[[include:FL_TMEM30A.md]]

          +[[include:tables/DLBCL_TMEM30A.md]]

          +[[include:tables/FL_TMEM30A.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_TMEM30A.md]]

          +[[include:tables/dnds_TMEM30A.md]]

           ## TMEM30A Hotspots

				TMSB4X.md
			
          @@ -18,12 +18,12 @@ TMSB4X is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_TMSB4X.md]]

          -[[include:FL_TMSB4X.md]]

          +[[include:tables/DLBCL_TMSB4X.md]]

          +[[include:tables/FL_TMSB4X.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_TMSB4X.md]]

          +[[include:tables/dnds_TMSB4X.md]]

           ## aSHM regions

				TNF.md
			
          @@ -18,9 +18,9 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:BL_TNF.md]]

          -[[include:DLBCL_TNF.md]]

          -[[include:FL_TNF.md]]

          +[[include:tables/BL_TNF.md]]

          +[[include:tables/DLBCL_TNF.md]]

          +[[include:tables/FL_TNF.md]]

           [[include:mermaid_TNF.md]]

				TNFAIP3.md
			
          @@ -18,12 +18,12 @@ Driver mutations affecting this gene in FL/DLBCL have been experimentally demons

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_TNFAIP3.md]]

          -[[include:FL_TNFAIP3.md]]

          +[[include:tables/DLBCL_TNFAIP3.md]]

          +[[include:tables/FL_TNFAIP3.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_TNFAIP3.md]]

          +[[include:tables/dnds_TNFAIP3.md]]

           ## TNFAIP3 Hotspots

				TNFRSF14.md
			
          @@ -20,12 +20,12 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_TNFRSF14.md]]

          -[[include:FL_TNFRSF14.md]]

          +[[include:tables/DLBCL_TNFRSF14.md]]

          +[[include:tables/FL_TNFRSF14.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_TNFRSF14.md]]

          +[[include:tables/dnds_TNFRSF14.md]]

           ## TNFRSF14 Hotspots

				TOP2A.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_TOP2A.md]]

          +[[include:tables/dnds_TOP2A.md]]

				TOX.md
			
          @@ -14,11 +14,11 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_TOX.md]]

          +[[include:tables/DLBCL_TOX.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_TOX.md]]

          +[[include:tables/dnds_TOX.md]]

           ## TOX Hotspots

				TP53.md
			
          @@ -19,13 +19,13 @@ Driver mutations affecting this gene in BL/FL/DLBCL have been experimentally dem

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_TP53.md]]

          -[[include:FL_TP53.md]]

          -[[include:BL_TP53.md]]

          +[[include:tables/DLBCL_TP53.md]]

          +[[include:tables/FL_TP53.md]]

          +[[include:tables/BL_TP53.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_TP53.md]]

          +[[include:tables/dnds_TP53.md]]

           [[include:browser_TP53.md]]

				TPP1.md
			
          @@ -20,7 +20,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_TPP1.md]]

          +[[include:tables/dnds_TPP1.md]]

				TPST2.md
			
          @@ -27,7 +27,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_TPST2.md]]

          +[[include:tables/dnds_TPST2.md]]

				TRAF3.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_TRAF3.md]]

          +[[include:tables/dnds_TRAF3.md]]

           ## Visualizations

				TRAF6.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_TRAF6.md]]

          +[[include:tables/dnds_TRAF6.md]]

           ## TRAF6 Hotspots

				TRIP12.md
			
          @@ -11,7 +11,7 @@ nocite: |

           |Entity|Tier|Description               |

           |:------:|:----:|--------------------------|

          -|![DLBCL](images/icons/DLBCL_tier1.png) |1   |high-confidence DLBCL gene|

          +|![DLBCL](images/icons/tables/DLBCL_tier1.png) |1   |high-confidence DLBCL gene|

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

				TRRAP.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_TRRAP.md]]

          +[[include:tables/dnds_TRRAP.md]]

				TTN.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_TTN.md]]

          +[[include:tables/dnds_TTN.md]]

           ## TTN Hotspots

				Template.md
			
          @@ -25,17 +25,17 @@ nocite: |

           *sub headings per file here unless there is just one*

           ### DLBCL

          -[[include:DLBCL_BCL2.md]]

          +[[include:tables/DLBCL_BCL2.md]]

           ### FL

          -[[include:FL_BCL2.md]]

          +[[include:tables/FL_BCL2.md]]

           ### BL

          -[[include:BL_BCL2.md]]

          +[[include:tables/BL_BCL2.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_BCL2.md]]

          +[[include:tables/dnds_BCL2.md]]

           ## aSHM regions

				Template_Relevance.md
			
          @@ -3,7 +3,7 @@

           |Entity|Tier|Description                           |

           |:------:|:----:|--------------------------------------|

          -|![DLBCL](images/icons/DLBCL_tier1.png) |[1](DLBCL_genes#tier-1-dlbcl-genes)|high-confidence DLBCL gene    |

          -|![FL](images/icons/FL_tier1.png)    |1   |high-confidence FL gene|

          -|![PMBL](images/icons/PMBL_tier2.png)|2|relevance in PMBL/cHL/GZL not firmly established|

          -|![BL](images/icons/BL_tier2.png)    |[2](BL_genes#tier-2-bl-genes)   |relevance in BL not firmly established|

          +|![DLBCL](images/icons/tables/DLBCL_tier1.png) |[1](DLBCL_genes#tier-1-dlbcl-genes)|high-confidence DLBCL gene    |

          +|![FL](images/icons/tables/FL_tier1.png)    |1   |high-confidence FL gene|

          +|![PMBL](images/icons/PMtables/BL_tier2.png)|2|relevance in PMBL/cHL/GZL not firmly established|

          +|![BL](images/icons/tables/BL_tier2.png)    |[2](BL_genes#tier-2-bl-genes)   |relevance in BL not firmly established|

				UBE2A.md
			
          @@ -14,11 +14,11 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_UBE2A.md]]

          +[[include:tables/DLBCL_UBE2A.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_UBE2A.md]]

          +[[include:tables/dnds_UBE2A.md]]

           [[include:browser_UBE2A.md]]

				UBE2J1.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_UBE2J1.md]]

          +[[include:tables/dnds_UBE2J1.md]]

           ## aSHM regions

				UBR5.md
			
          @@ -29,7 +29,7 @@ Mutations in this gene were first described in DLBCL in 2013[@zhangGeneticHetero

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_UBR5.md]]

          +[[include:tables/dnds_UBR5.md]]

				UNC5B.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_UNC5B.md]]

          +[[include:tables/dnds_UNC5B.md]]

           [[include:browser_UNC5B.md]]

				UNC5C.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_UNC5C.md]]

          +[[include:tables/dnds_UNC5C.md]]

				UNC5D.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_UNC5D.md]]

          +[[include:tables/dnds_UNC5D.md]]

				USP7.md
			
          @@ -14,12 +14,12 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_USP7.md]]

          -[[include:BL_USP7.md]]

          +[[include:tables/DLBCL_USP7.md]]

          +[[include:tables/BL_USP7.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_USP7.md]]

          +[[include:tables/dnds_USP7.md]]

           [[include:browser_USP7.md]]

				VMA21.md
			
          @@ -18,14 +18,14 @@ Driver mutations affecting this gene in FL have been experimentally demonstrated

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

           ### FL

          -[[include:FL_VMA21.md]]

          +[[include:tables/FL_VMA21.md]]

           ### DLBCL

          -[[include:DLBCL_VMA21.md]]

          +[[include:tables/DLBCL_VMA21.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_VMA21.md]]

          +[[include:tables/dnds_VMA21.md]]

           [[include:browser_VMA21.md]]

				VWA7.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_VWA7.md]]

          +[[include:tables/dnds_VWA7.md]]

				WAC.md
			
          @@ -28,7 +28,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_WAC.md]]

          +[[include:tables/dnds_WAC.md]]

				WDFY3.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_WDFY3.md]]

          +[[include:tables/dnds_WDFY3.md]]

				WDR7.md
			
          @@ -30,7 +30,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_WDR7.md]]

          +[[include:tables/dnds_WDR7.md]]

				WDR90.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_WDR90.md]]

          +[[include:tables/dnds_WDR90.md]]

				WEE1.md
			
          @@ -17,11 +17,11 @@ WEE1 is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm) 

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_WEE1.md]]

          +[[include:tables/DLBCL_WEE1.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_WEE1.md]]

          +[[include:tables/dnds_WEE1.md]]

           ## aSHM regions

				WHAMM.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_WHAMM.md]]

          +[[include:tables/dnds_WHAMM.md]]

				WNK1.md
			
          @@ -14,12 +14,12 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_WNK1.md]]

          -[[include:BL_WNK1.md]]

          +[[include:tables/DLBCL_WNK1.md]]

          +[[include:tables/BL_WNK1.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_WNK1.md]]

          +[[include:tables/dnds_WNK1.md]]

           ## WNK1 Hotspots

				WNK2.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_WNK2.md]]

          +[[include:tables/dnds_WNK2.md]]

				XBP1.md
			
          @@ -11,7 +11,7 @@ nocite: |

           |Entity|Tier|Description                              |

           |:------:|:----:|-----------------------------------------|

          -|![DLBCL](images/icons/DLBCL_tier2.png) |2-a | aSHM target; Although recurrent, the relevance of mutations in DLBCL is tenuous |

          +|![DLBCL](images/icons/tables/DLBCL_tier2.png) |2-a | aSHM target; Although recurrent, the relevance of mutations in DLBCL is tenuous |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

				XIRP2.md
			
          @@ -20,7 +20,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_XIRP2.md]]

          +[[include:tables/dnds_XIRP2.md]]

				XPO1.md
			
          @@ -19,11 +19,11 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_XPO1.md]]

          +[[include:tables/DLBCL_XPO1.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_XPO1.md]]

          +[[include:tables/dnds_XPO1.md]]

           ## XPO1 Hotspots

				YY1.md
			
          @@ -30,7 +30,7 @@ Mutations in this gene were reported to be inflated in the original results acco

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_YY1.md]]

          +[[include:tables/dnds_YY1.md]]

				YY1AP1.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_YY1AP1.md]]

          +[[include:tables/dnds_YY1AP1.md]]

				ZAN.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ZAN.md]]

          +[[include:tables/dnds_ZAN.md]]

				ZBTB7A.md
			
          @@ -32,7 +32,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ZBTB7A.md]]

          +[[include:tables/dnds_ZBTB7A.md]]

				ZC3H12A.md
			
          @@ -18,13 +18,13 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_ZC3H12A.md]]

          -[[include:FL_ZC3H12A.md]]

          +[[include:tables/DLBCL_ZC3H12A.md]]

          +[[include:tables/FL_ZC3H12A.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ZC3H12A.md]]

          +[[include:tables/dnds_ZC3H12A.md]]

           [[include:browser_ZC3H12A.md]]

				ZCCHC7.md
			
          @@ -14,12 +14,12 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_ZCCHC7.md]]

          +[[include:tables/DLBCL_ZCCHC7.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ZCCHC7.md]]

          +[[include:tables/dnds_ZCCHC7.md]]

           ## aSHM regions

				ZEB2.md
			
          @@ -28,7 +28,7 @@ Mutations in this gene were first described in DLBCL in 2013[@zhangGeneticHetero

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ZEB2.md]]

          +[[include:tables/dnds_ZEB2.md]]

				ZFAT.md
			
          @@ -28,7 +28,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ZFAT.md]]

          +[[include:tables/dnds_ZFAT.md]]

				ZFP36L1.md
			
          @@ -17,12 +17,12 @@ ZFP36L1 is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ash

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_ZFP36L1.md]]

          -[[include:BL_ZFP36L1.md]]

          +[[include:tables/DLBCL_ZFP36L1.md]]

          +[[include:tables/BL_ZFP36L1.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ZFP36L1.md]]

          +[[include:tables/dnds_ZFP36L1.md]]

           ## aSHM regions

				ZFX.md
			
          @@ -31,7 +31,7 @@ Mutations in this gene were reported to be inflated in the original results acco

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ZFX.md]]

          +[[include:tables/dnds_ZFX.md]]

				ZNF217.md
			
          @@ -14,13 +14,13 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_ZNF217.md]]

          -[[include:FL_ZNF217.md]]

          -[[include:BL_ZNF217.md]]

          +[[include:tables/DLBCL_ZNF217.md]]

          +[[include:tables/FL_ZNF217.md]]

          +[[include:tables/BL_ZNF217.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ZNF217.md]]

          +[[include:tables/dnds_ZNF217.md]]

				ZNF229.md
			
          @@ -23,11 +23,11 @@ Due to [minimal support](ZNF229#representative-mutation) in the original primary

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:BL_ZNF229.md]]

          +[[include:tables/BL_ZNF229.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ZNF229.md]]

          +[[include:tables/dnds_ZNF229.md]]

				ZNF292.md
			
          @@ -14,11 +14,11 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_ZNF292.md]]

          +[[include:tables/DLBCL_ZNF292.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ZNF292.md]]

          +[[include:tables/dnds_ZNF292.md]]

           [[include:browser_ZNF292.md]]

				ZNF423.md
			
          @@ -23,7 +23,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ZNF423.md]]

          +[[include:tables/dnds_ZNF423.md]]

				ZNF608.md
			
          @@ -14,12 +14,12 @@ nocite: |

           ## Mutation incidence in large patient cohorts (GAMBL reanalysis)

          -[[include:DLBCL_ZNF608.md]]

          -[[include:FL_ZNF608.md]]

          +[[include:tables/DLBCL_ZNF608.md]]

          +[[include:tables/FL_ZNF608.md]]

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ZNF608.md]]

          +[[include:tables/dnds_ZNF608.md]]

           [[include:browser_ZNF608.md]]

				ZNF85.md
			
          @@ -22,7 +22,7 @@ nocite: |

           ## Mutation pattern and selective pressure estimates

          -[[include:dnds_ZNF85.md]]

          +[[include:tables/dnds_ZNF85.md]]

				test.md
			
          @@ -16,7 +16,7 @@ link-citations: true

              <th style="text-align:right;"> Dana-Farber </th>

              <th style="text-align:right;"> NCI </th>

              <th style="text-align:right;"> Reddy[@reddyGeneticFunctionalDrivers2017] </th>

          -   <th style="text-align:right;"> DLBCL_ICGC </th>

          +   <th style="text-align:right;"> tables/DLBCL_ICGC </th>

             </tr>

            </thead>

           <tbody>

...	...	@@ -14,7 +14,7 @@ nocite: \|
14	14
15	15	## Mutation incidence in large patient cohorts (GAMBL reanalysis)
16	16
17		-[[include:DLBCL_ABCA3.md]]
	17	+[[include:tables/DLBCL_ABCA3.md]]
18	18
19	19	[[include:mermaid_ABCA3.md]]
20	20

...	...	@@ -14,7 +14,7 @@ nocite: \|
14	14
15	15	## Mutation incidence in large patient cohorts (GAMBL reanalysis)
16	16
17		-[[include:FL_ABL2.md]]
	17	+[[include:tables/FL_ABL2.md]]
18	18
19	19	## Mutation pattern and selective pressure estimates
20	20

...	...	@@ -24,7 +24,7 @@ Due to [minimal support](ACAD9#representative-mutation) in the original primary
24	24	## Mutation incidence in large patient cohorts (GAMBL reanalysis)
25	25
26	26	### BL
27		-[[include:BL_ACAD9]]
	27	+[[include:tables/BL_ACAD9]]
28	28
29	29	## Mutation pattern and selective pressure estimates
30	30

...	...	@@ -24,7 +24,7 @@ Due to [minimal support](ACE#representative-mutation) in the original primary da
24	24
25	25	## Mutation incidence in large patient cohorts (GAMBL reanalysis)
26	26
27		-[[include:BL_ACE]]
	27	+[[include:tables/BL_ACE]]
28	28
29	29	## Mutation pattern and selective pressure estimates
30	30

...	...	@@ -17,7 +17,7 @@ nocite: \|
17	17
18	18	## Mutation incidence in large patient cohorts (GAMBL reanalysis)
19	19
20		-[[include:DLBCL_ACSS2]]
	20	+[[include:tables/DLBCL_ACSS2]]
21	21
22	22	[[include:mermaid_ACSS2.md]]
23	23

...	...	@@ -17,7 +17,7 @@ nocite: \|
17	17
18	18	## Mutation incidence in large patient cohorts (GAMBL reanalysis)
19	19
20		-[[include:DLBCL_ACSS3.md]]
	20	+[[include:tables/DLBCL_ACSS3.md]]
21	21
22	22	[[include:mermaid_ACSS3.md]]
23	23

...	...	@@ -21,12 +21,12 @@ ACTB is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm)
21	21
22	22	## Mutation incidence in large patient cohorts (GAMBL reanalysis)
23	23
24		-[[include:DLBCL_ACTB.md]]
25		-[[include:FL_ACTB.md]]
	24	+[[include:tables/DLBCL_ACTB.md]]
	25	+[[include:tables/FL_ACTB.md]]
26	26
27	27	## Mutation pattern and selective pressure estimates
28	28
29		-[[include:dnds_ACTB.md]]
	29	+[[include:tables/dnds_ACTB.md]]
30	30
31	31	## aSHM regions
32	32

...	...	@@ -23,12 +23,12 @@ The function of mutations in ACTB and ACTG1 have not yet been determined.[@witje
23	23
24	24	## Mutation incidence in large patient cohorts (GAMBL reanalysis)
25	25
26		-[[include:DLBCL_ACTG1.md]]
27		-[[include:FL_ACTG1.md]]
	26	+[[include:tables/DLBCL_ACTG1.md]]
	27	+[[include:tables/FL_ACTG1.md]]
28	28
29	29	## Mutation pattern and selective pressure estimates
30	30
31		-[[include:dnds_ACTG1.md]]
	31	+[[include:tables/dnds_ACTG1.md]]
32	32
33	33	## aSHM regions
34	34

...	...	@@ -17,7 +17,7 @@ nocite: \|
17	17
18	18	## Mutation incidence in large patient cohorts (GAMBL reanalysis)
19	19
20		-[[include:DLBCL_ACTN1]]
	20	+[[include:tables/DLBCL_ACTN1]]
21	21
22	22	[[include:mermaid_ACTN1.md]]
23	23

...	...	@@ -18,7 +18,7 @@ nocite: \|
18	18	## Mutation incidence in large patient cohorts (GAMBL reanalysis)
19	19
20	20
21		-[[include:DLBCL_ADAM2.md]]
	21	+[[include:tables/DLBCL_ADAM2.md]]
22	22
23	23	[[include:mermaid_ADAM2.md]]
24	24

...	...	@@ -19,11 +19,11 @@ Mutations in this gene were first described in DLBCL in 2021 by Hübschmann et a
19	19
20	20	## Mutation incidence in large patient cohorts (GAMBL reanalysis)
21	21
22		-[[include:DLBCL_ADAMTS1]]
	22	+[[include:tables/DLBCL_ADAMTS1]]
23	23
24	24	## Mutation pattern and selective pressure estimates
25	25
26		-[[include:dnds_ADAMTS1.md]]
	26	+[[include:tables/dnds_ADAMTS1.md]]
27	27
28	28
29	29

...	...	@@ -17,7 +17,7 @@ nocite: \|
17	17
18	18	## Mutation incidence in large patient cohorts (GAMBL reanalysis)
19	19
20		-[[include:DLBCL_ADAMTS15.md]]
	20	+[[include:tables/DLBCL_ADAMTS15.md]]
21	21
22	22	[[include:mermaid_ADAMTS15.md]]
23	23

...	...	@@ -16,11 +16,11 @@ nocite: \|
16	16
17	17	### BL
18	18
19		-[[include:BL_ADAMTS5.md]]
	19	+[[include:tables/BL_ADAMTS5.md]]
20	20
21	21	## Mutation pattern and selective pressure estimates
22	22
23		-[[include:dnds_ADAMTS5.md]]
	23	+[[include:tables/dnds_ADAMTS5.md]]
24	24
25	25
26	26	[[include:browser_ADAMTS5.md]]

...	...	@@ -17,7 +17,7 @@ nocite: \|
17	17
18	18	## Mutation incidence in large patient cohorts (GAMBL reanalysis)
19	19
20		-[[include:DLBCL_ADAMTSL3.md]]
	20	+[[include:tables/DLBCL_ADAMTSL3.md]]
21	21
22	22	[[include:mermaid_ADAMTSL3.md]]
23	23

...	...	@@ -17,7 +17,7 @@ nocite: \|
17	17
18	18	## Mutation incidence in large patient cohorts (GAMBL reanalysis)
19	19
20		-[[include:DLBCL_ADH7.md]]
	20	+[[include:tables/DLBCL_ADH7.md]]
21	21
22	22	[[include:mermaid_ADH7.md]]
23	23

...	...	@@ -14,11 +14,11 @@ nocite: \|
14	14
15	15	## Mutation incidence in large patient cohorts (GAMBL reanalysis)
16	16
17		-[[include:BL_ADNP.md]]
	17	+[[include:tables/BL_ADNP.md]]
18	18
19	19	## Mutation pattern and selective pressure estimates
20	20
21		-[[include:dnds_ADNP.md]]
	21	+[[include:tables/dnds_ADNP.md]]
22	22
23	23
24	24

...	...	@@ -18,11 +18,11 @@ nocite: \|
18	18
19	19	## Mutation incidence in large patient cohorts (GAMBL reanalysis)
20	20
21		-[[include:DLBCL_AFAP1L2.md]]
	21	+[[include:tables/DLBCL_AFAP1L2.md]]
22	22
23	23	## Mutation pattern and selective pressure estimates
24	24
25		-[[include:dnds_AFAP1L2.md]]
	25	+[[include:tables/dnds_AFAP1L2.md]]
26	26
27	27	[[include:mermaid_AFAP1L2.md]]
28	28

...	...	@@ -14,11 +14,11 @@ nocite: \|
14	14
15	15	## Mutation incidence in large patient cohorts (GAMBL reanalysis)
16	16
17		-[[include:BL_AGO4]]
	17	+[[include:tables/BL_AGO4]]
18	18
19	19	## Mutation pattern and selective pressure estimates
20	20
21		-[[include:dnds_AGO4.md]]
	21	+[[include:tables/dnds_AGO4.md]]
22	22
23	23
24	24

...	...	@@ -14,11 +14,11 @@ nocite: \|
14	14
15	15	## Mutation incidence in large patient cohorts (GAMBL reanalysis)
16	16
17		-[[include:DLBCL_AICDA.md]]
	17	+[[include:tables/DLBCL_AICDA.md]]
18	18
19	19	## Mutation pattern and selective pressure estimates
20	20
21		-[[include:dnds_AICDA.md]]
	21	+[[include:tables/dnds_AICDA.md]]
22	22
23	23	## aSHM regions
24	24

...	...	@@ -17,7 +17,7 @@ nocite: \|
17	17
18	18	## Mutation incidence in large patient cohorts (GAMBL reanalysis)
19	19
20		-[[include:DLBCL_ALAS1]]
	20	+[[include:tables/DLBCL_ALAS1]]
21	21
22	22	[[include:mermaid_ALAS1.md]]
23	23

...	...	@@ -20,11 +20,11 @@ nocite: \|
20	20
21	21	## Mutation incidence in large patient cohorts (GAMBL reanalysis)
22	22
23		-[[include:BL_ALPK2.md]]
	23	+[[include:tables/BL_ALPK2.md]]
24	24
25	25	## Mutation pattern and selective pressure estimates
26	26
27		-[[include:dnds_ALPK2.md]]
	27	+[[include:tables/dnds_ALPK2.md]]
28	28
29	29
30	30

...	...	@@ -20,7 +20,7 @@ nocite: \|
20	20
21	21	## Mutation pattern and selective pressure estimates
22	22
23		-[[include:dnds_ANK2.md]]
	23	+[[include:tables/dnds_ANK2.md]]
24	24
25	25
26	26

...	...	@@ -27,7 +27,7 @@ Mutations in this gene were first described in DLBCL in 2021 by Hübschmann et a
27	27
28	28	## Mutation pattern and selective pressure estimates
29	29
30		-[[include:dnds_ANKRD12.md]]
	30	+[[include:tables/dnds_ANKRD12.md]]
31	31
32	32	[[include:browser_ANKRD12.md]]
33	33

...	...	@@ -23,7 +23,7 @@ nocite: \|
23	23
24	24	## Mutation pattern and selective pressure estimates
25	25
26		-[[include:dnds_ANKRD17.md]]
	26	+[[include:tables/dnds_ANKRD17.md]]
27	27
28	28
29	29	[[include:browser_ANKRD17.md]]

...	...	@@ -22,7 +22,7 @@ nocite: \|
22	22
23	23	## Mutation pattern and selective pressure estimates
24	24
25		-[[include:dnds_ARHGEF1.md]]
	25	+[[include:tables/dnds_ARHGEF1.md]]
26	26
27	27
28	28

...	...	@@ -23,14 +23,14 @@ Driver mutations affecting this gene have been experimentally demonstrated to ca
23	23
24	24	## Mutation incidence in large cohorts
25	25
26		-[[include:DLBCL_ARID1A.md]]
27		-[[include:FL_ARID1A.md]]
28		-[[include:BL_ARID1A.md]]
	26	+[[include:tables/DLBCL_ARID1A.md]]
	27	+[[include:tables/FL_ARID1A.md]]
	28	+[[include:tables/BL_ARID1A.md]]
29	29
30	30
31	31	## Mutation pattern and selective pressure estimates
32	32
33		-[[include:dnds_ARID1A.md]]
	33	+[[include:tables/dnds_ARID1A.md]]
34	34
35	35	[[include:browser_ARID1A.md]]
36	36

...	...	@@ -30,7 +30,7 @@ nocite: \|
30	30
31	31	## Mutation pattern and selective pressure estimates
32	32
33		-[[include:dnds_ARID1B.md]]
	33	+[[include:tables/dnds_ARID1B.md]]
34	34
35	35
36	36	[[include:browser_ARID1B.md]]

...	...	@@ -29,7 +29,7 @@ nocite: \|
29	29
30	30	## Mutation pattern and selective pressure estimates
31	31
32		-[[include:dnds_ARID5B.md]]
	32	+[[include:tables/dnds_ARID5B.md]]
33	33
34	34	[[include:browser_ARID5B.md]]
35	35

...	...	@@ -23,11 +23,11 @@ Driver mutations affecting this gene in DLBCL have been experimentally demonstra
23	23
24	24	## Mutation incidence in large patient cohorts (GAMBL reanalysis)
25	25
26		-[[include:DLBCL_ATM.md]]
	26	+[[include:tables/DLBCL_ATM.md]]
27	27
28	28	## Mutation pattern and selective pressure estimates
29	29
30		-[[include:dnds_ATM.md]]
	30	+[[include:tables/dnds_ATM.md]]
31	31
32	32
33	33	[[include:browser_ATM.md]]

...	...	@@ -33,7 +33,7 @@ Due to [minimal support](ATP2C2#representative-mutation) in the original primary
33	33
34	34	## Mutation pattern and selective pressure estimates
35	35
36		-[[include:dnds_ATP2C2.md]]
	36	+[[include:tables/dnds_ATP2C2.md]]
37	37
38	38
39	39